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INTRODUCTION 
Documentation of human herpesvirus infections extends 
back to the ancient Greeks. · Indeed, the word "herpes" de-
rives from a Greek word meaning "to creep or crawl", a ref-
erence to the way skin lesions spread in infected individuals 
(19,225). However, modern scholarship in the study of herpes 
simplex virus did not begin until the late 1960s. It was in 
1968 when Nahmias and Dowdle first demonstrated the existence 
of two antigenic strains of the virus, and furthermore that 
herpes simplex type 1 (HSV-1) was associated with infections 
above the belt (nongenital infection) while herpes simplex 
type 2 (HSV-2} was associated with infection below the belt 
(genital herpes} (135}. The following 20-odd years has led 
to many dramatic developments in the field, but numerous 
questions about the biology of herpes simplex virus remain. 
The two strains of herpes simplex virus belong to the 
family Herpesviridae (123}. Members of this family share 
several features. All have a large, linear double-stranded 
DNA genome, wrapped around a fibrillar spool, enclosed in the 
core of the virion. The core is surrounded by an icosahedral 
nucleocapsid, consisting of 162 capsomeres. The nucleocapsid 
is enclosed in an amorphous material called the tegument. 
The entire structure is then housed in an envelope covered 
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with viral glycoprotein spikes. 
Herpesviruses are ubiquitous in nature. Upon examina-
tion, most vertebrate species can be infected by at least one 
herpesvirus. The range extends from humans and other pri-
mates, through horses, cattle, pigs, chickens, and fish. 
These viruses fall into one of three subfamilies (58). 
Members of the subfamily Alphaherpesvirinae have a variable 
host range, reproduce relatively quickly, spread rapidly in 
culture, destroy infected cells efficiently, and can estab-
lish latent infections in nerve ganglia. This subfamily con-
tains two genera, Simplexvirus, which includes HSV-1 and HSV-
2, and Varicellavirus, which includes varicella-zoster virus 
(the causative agent of chicken pox and shingles) and pseudo-
rabies virus (which infects pigs). 
Members of the second subfamily, the Betaherpesvirinae, 
are characterized by a more restricted host range than the 
Alphaherpesvirinae, a long reproductive cycle, and slow 
growth in culture. Infected cells often become enlarged 
(cytomegalia). These viruses can maintain latent infections 
in secretory glands, lymphoreticular cells, kidneys, and 
other tissues. The primary genus in this subfamily is Cyto-
megalovirus, with both human and murine representatives. 
The subfamily Gammaherpesvirinae contains members whose 
experimental host range is very limited. .In vitro, these 
viruses all can replicate in lymphoblastoid cells, with 
specificity for either T or B cells. Latent infection is 
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typically in these lymphoid tissues. The principal genus is 
the Lymphocryptovirus, the archetype being Epstein-Barr vi-
rus, the causative agent of infectious mononucleosis. The 
Gammaherpesvirinae also contain the recently identified human 
herpesvirus 6. 
Despite this recent discovery, as well as descriptions 
of nearly 100 other herpesviruses, the majority of the extant 
information comes from studies involving HSV-1 and HSV-2. 
Much is known on the biology, morphology, and genetics of 
these viruses exists, some of which will be reviewed below. 
Viral Replication 
Sequence analysis indicates that HSV-1 contains 74 open 
reading frames encoding 72 polypeptides (two of the open 
reading frames are reiterated; 126}. Of that number, at 
least 33 are designated as virion polypeptides (77). Eight 
of these virion proteins are glycosylated and are found on 
the surface of the virion. These glycoproteins are involved 
mainly in the attachment to and penetration of the host cell. 
Glycoprotein B (gB} and gC are primarily responsible for 
attachment to receptor molecules on the surface of the host 
cells (110,227). The recently reported gH is required early 
in infection, although it may be involved in penetration 
rather than attachment (28}. 
Penetration of the host cell is a multistep event in-
volving several of the glycoproteins. Penetration is thought 
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to occur not by phagocytosis but rather by fusion of the 
viral envelope with the plasma membrane (131). Two virion 
glycoproteins, gB and gD, are implicated in this fusion pro-
cess. A temperature sensitive mutation in gB leads to a vi-
rus that can attach but not penetrate host cells (121}. 
Likewise, viruses carrying a deletion of gB can only attach 
to host cells (30). Deletion of gD leads to the same pheno-
type (93}. In cell culture, gc, gE, gG, gI, and gJ are all 
dispensable, for either entry or egress of viral particles 
(223). The other three glycoproteins, gB, gD, and gH are es-
sential. 
Once the virus penetrates the plasma membrane, the in-
tact nucleocapsid is transported to the nuclear pores. The 
viral DNA is then released into the nucleoplasm. Infection 
with wild type virus leads to accumulation of empty nucleo-
capsids at the nuclear pores, and parental viral DNA accumu-
lates in the nucleus. This event requires a viral function, 
as the temperature sensitive mutant HSV-l(HFEM}.:t.§.B7 accumu-
lates at nuclear pores and only releases its DNA upon down-
shift to the permissive temperature (11). 
The HSV genome has a structure unique to the Herpesviri-
dae (Figure 1). The genome is approximately 150 kilobase 
pairs in size, with a 68% G+C content (HSV-1), or 69% G+C 
content (HSV-2} (13,100). The genome consists of two cova-
lently linked segments, L (long) ands (short). Each segment 
contains unique sequences bracketed by inverted repeats 
5 
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Figure 1. Schematic Diagram of the Herpes Simplex Type 1 
Genome. The four possible isomeric forms of the wild type 
genome are diagrammed here: Pis the prototypical isomer, I 8 
is inverted in the s segment, IL is inverted in the L seg-
ment, and I~ is inverted in both the Sand L segments. The 
arrows refer to the orientation of the segments relative to 
the P isomer. Refer to the text for other definitions. 
( 194) . 
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The repeats on the L segment are designated ab and 
b'a', whereas the repeats of the s component are called ca 
and a'c' (219). The genome can be represented schematically 
thus: 
aLanb - UL - b'a'mc' - Us - cas 
where aL and as are terminal A sequences as defined below, an 
and am are terminal A sequences directly repeated zero or 
more times (n) or present in one to many copies (m), UL is 
the large unique component, and Us is the small unique compo-
nent (116,165). 
The A sequence has a highly conserved structure, but 
contains an inconstant number of repeat elements. The repeat 
elements of the HSV-1 strain F have been defined, where the A 
sequence consists of a 20 base pair direct repeat called DRl, 
a 65 base pair unique sequence designated ub, a 12 base pair 
direct repeat (DR2) present in 19-23 copies per s sequence, a 
37 base pair direct repeat (DR4) present in two to three cop-
ies, a 58 base pair unique sequence (Uc), and finally another 
copy of DRl (128,129). The number of copies of DR2 and DR4 
determine the size of the A sequence for a given strain. The 
A sequence can be schematically represented as: 
DRl - ub - DR2D - DR4m - Uc - DRl 
where n and mare the number of copies of DR2 and DR4 respec-
tively. 
The most unique feature of this genome is that the Land 
s components can invert relative to one another. These in-
7 
versions yield four distinct isomers, designated as P (proto-
type), IL (inversion of the L component), I 8 (inversion of the 
s component), and I~ (inversion of both the sand L compo-
nents) (45, 76). Wild type isolates can carry any one of 
these four isomers with a 25% probability. However, genomes 
"frozen" in a particular isomer by deletion of the internal 
inverted repeats generate viable progeny (92,157). There-
fore, the reason for this isomerization is unclear. 
Regardless of the isomer involved, once the genome is 
liberated into the nucleoplasm, viral gene expression begins. 
Viral genes are expressed in one of three broad kinetic 
classes, designated a (immediate-early), /3 (early), and -y 
(late). These three classes are "coordinately controlled in 
a cascade fashion" (82), such that a gene products regulate 
the expression of /3 genes, whose products subsequently con-
trol the expression of -y genes (82). The regulation of a 
gene transcription is effected by a component of the incoming 
virion, called a-trans-induction factor (aTIF) or Vmw 65 (12, 
31). A cis-acting site has been identified in the 5' non-
coding region of all five a genes (105). A host nuclear pro-
tein binds to this site (65,141); aTIF binds to the ensuing 
nuclear protein-viral DNA complex, or binds the nuclear pro-
tein and this protein-protein complex then binds the cis-
acting site (158,212). This interaction presumably allows 
aTIF to transactivate a gene transcription. 
Notwithstanding the precise mechanism of trans-activa-
8 
tion, the a genes can be operationally defined as those ca-
pable of being expressed in the absence of any other viral 
gene expression (153). There are five such genes, whose 
products are designated as infected cell polypeptides (ICP) 
o, 4, 22, 27, and 47. The synthesis of these proteins can be 
detected as early as one hour post infection (p. i.), peaks 
around two to four hours p. i., and declines thereafter (83). 
All a proteins, with the possible exception of ICP47, are 
thought to have regulatory functions. ICP4 , is the best 
characterized a protein, and it is essential throughout 
infection for efficient transcription of all classes of viral 
genes (47). One interesting set of ts mutants in ICP4 over-
produces a proteins but fails to induce the expression of any 
other class of viral genes (46,222). 
The a protein ICP27 is also essential. Deletion mu-
tants exhibit reduced synthesis of viral DNA and a virtual 
absence of late gene expression ( 124) • Analysis of viral 
mutants as well as results from transient expression assays 
indicate that ICP27 has either positive or negative regula-
tory effects, depending upon the gene examined (51,163). 
ICPO, another of the a proteins, has been examined 
primarily through the use of transient expression systems. 
These studies suggest that ICPO can trans-activate co-trans-
fected viral genes, either alone or in concert with ICP4 (52, 
64,142) • Deletion of the gene for ICPO does not greatly 
reduce the growth of mutant viruses in tissue culture (181, 
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203). These mutants produce significant amounts of viral DNA 
and exhibit only a small reduction in the synthesis of late 
proteins compared to wild type. 
ICP22 deletion mutants make viral DNA but do not express 
late genes effectively, although this appears to depend upon 
the host cell used for infection (191). As a group, then, 
the a proteins play a major role in all subsequent viral gene 
expression, although ICP4 and ICP27 appear to be the only es-
sential a proteins. 
Expression of fJ genes requires the presence of func-
tional a proteins, and fJ polypeptide synthesis peaks at five 
to seven hours p. i. (83). The fJ genes are divided into two 
kinetically distinct classes, namely fJ1 and fJ2 • The fJ1 class 
appears very early in infection, and its members have been 
mistaken for a proteins (36). In fact, fJ1 genes differ from 
a genes by the requirement of the former for functional ICP4 
for their synthesis (81,82). Representative fJ1 genes include 
the one coding for the large subunit of the viral ribonucleo-
tide reductase (ICP6) and the gene for the major DNA-binding 
protein (ICP8). The latter is an essential gene, required 
for the synthesis of viral DNA (40, 66) and control of later 
viral gene expression ( 67, 68) • The {J2 class includes the 
genes for the viral thymidine kinase and DNA polymerase. 
Most of these genes are involved in the synthesis of viral 
DNA, an event that heralds the onset of~ gene expression. 
The late, or~, genes have been divided into two groups, 
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'Yi and -y2 , depending on the stringency of their requirement 
for DNA synthesis (41,80). Prototypical -y1 genes include the 
genes for glycoprotein Band H, and the major capsid protein 
gene (ICP5). The expression of these genes is somewhat 
affected by DNA synthesis inhibitors, probably as a result of 
gene dosage effects. As the number of genome copies de-
creases, so too does the expression of the -y1 genes. In con-
trast, the expression of -y2 genes, such as the glycoprotein C 
gene, is totally repressed in the presence of DNA synthesis 
inhibitors (82,83). As a group, the 'Y gene products become 
structural components of the progeny virions, which appear as 
early as 12 hours p. i. 
Viral DNA Synthesis 
The synthesis of viral DNA can be detected as early as 
three hours after the start of infection, and proceeds at 
least until 15 hours p. i. (166,167). Of the starting (pa-
rental) DNA, only a small fraction is actually replicated 
(89). Although within the virus the viral DNA is linear, in 
the infected cell, free ends of viral DNA cannot be detected. 
The DNA is either circular, or in head-to-tail concatamers 
(88). The evidence so far implies that herpes simplex virus 
replicates by a rolling-circle mechanism (15,88), although 
such a structure has not yet been isolated. 
The origins of replication of HSV DNA have been isolated 
and well defined. Origins were first defined by examining 
defective interfering viral genomes (59,198). 
11 
The current 
definition is functional. That is, an origin of replication 
is defined as those sequences required to allow a fragment of 
HSV DNA transfected into permissive cells to be amplified. 
This transfected fragment requires viral functions provided 
in trans, either by co-transfection with a viral genome or 
individual viral genes, or by infection with helper virus. 
Using this functional definition, HSV-1 has three origins of 
DNA replication. Two of these map to the repeat sequences of 
the S component. Ori81 is found between the promoters for 
the a genes encoding ICP4 and ICP22, whereas ori82 is situ-
ated between the ICP4 and ICP47 gene promoters (43,130, 202, 
218). The third origin, oriL, is in the middle of the L 
component, between the promoters for the major DNA-binding 
protein (ICPS) and the DNA polymerase, both /j genes (117, 
199). This third origin, oriL, consists of an A+T-rich, 144 
base pair perfect palindrome (118,224). The s component ori-
gins are shorter than oriL. They both contain an A+T-rich 
palindrome related to that of oriL, but the S component pal-
indrome is smaller and not perfectly symmetrical (202). 
Once the origins of viral DNA replication were described 
and defined, experimentation turned to defining the viral 
functions required in trans for that replication. Chalberg 
(34), in an elegant series of experiments, transfected a 
plasmid containing an origin of replication along with vari-
ous viral genes and looked for amplification of the plasmid. 
12 
seven essential genes were identified: a viral DNA polymerase 
(UL 30), a single-strand DNA binding protein (ICPS; UL 29), 
an origin binding protein (UL 52), a double-strand DNA bind-
ing protein (UL 42), and three additional protein which act 
as a complex with both primase and helicase functions (UL s, 
UL 8, and UL 9). Presumably these viral proteins act in con-
cert with cellular proteins to perform the essential task of 
replicating the viral DNA. There are undoubtedly other 
genes, both viral and cellular, that are needed for further 
processing and packaging of the newly replicated viral DNA. 
As mentioned above, the replicated viral DNA lacks free 
ends (88). This DNA must be processed and packaged into 
empty capsids. This involves amplification of a sequences 
and cleavage of the DNA into genome length. Isomerization of 
the DNA occurs throughout these events. Cleavage and packag-
ing are considered to occur simultaneously (44,109). The 
full capsids then are enveloped with modified nuclear mem-
branes (49,138) and are secreted via the Golgi apparatus in a 
manner similar to that of secreted cellular proteins {94). 
These events terminate the viral replication cycle. 
Effects of HSV Infection on the Host Cell 
one of the earliest structural changes of the host cell 
is the enlargement and fragmentation of the nucleolus. At 
the same time, host chromosomes are marginated, with the 
nucleus ultimately becoming distorted and multi lobed ( 164, 
I!"·· 
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168). The appearance of cellular membranes is also greatly 
altered at late times after infection. Both the nuclear and 
cytoplasmic membranes display thickened patches along their 
length; ultimately, these patches fold upon themselves, ap-
pearing as double membranes (131,138). 
The best studied effect of HSV infection is that on host 
macromolecular synthesis. There is a rapid and generalized 
cessation of a variety of host metabolic activities. Host 
DNA synthesis ceases (169), host protein synthesis rapidly 
declines (160,167,209) and host ribosomal RNA synthesis is 
curtailed (221). The most extensive information exists on 
the ability of the virus to shutoff host protein synthesis. 
This shutoff involves a virion structural component, and 
does not require any viral gene expression (56,139). There-
fore, this shutoff can occur in physically or chemically 
enucleated cells, in cells treated with transcription inhibi-
tors (dactinomycin) or translation inhibitors (cyclohexi-
mide), or in cells infected with UV-inactivated virus (55,56, 
107,160,184). Host shutoff is characterized by disaggrega-
tion of host polyribosomes (139), and destabilization and 
degradation of host messenger RNA (53,139,184). 
The unravelling of the mechanism of this shutoff began 
with the isolation of viruses with mutations in this func-
tion, called vhs (virion host shutoff) mutants (160). These 
mutants failed to induce rapid shutoff of host polypeptide 
synthesis, but unexpectedly also overproduced a polypeptides. 
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Indeed, the entire temporal pattern of viral gene expression 
was prolonged in these mutants. Still, these mutants inhib-
ited host protein synthesis late in a productive infection, 
although not as completely as wild type virus. This late 
shutoff was termed secondary shutoff by Read and Frenkel 
(160), and apparently is unrelated to the vhs gene, since a 
vhs deletion mutant still displays secondary shutoff (Read 
and Knight, unpublished data). 
Further studies on one particular mutant, designated vhs 
1, revealed that the functional stability of a mRNAs was 
increased in cells infected with this virus (143). In a 
later experimental tour de force, Oroskar and Read (144) sur-
veyed representative mRNAs from all kinetic classes to show 
that the half-lives of all messages examined were increased 
substantially in cells infected with vhs 1. This indicates 
that the vhs function is non-selective, and can affect the 
half-life of any mRNA present in the cell. 
Frenkel and colleagues (107,206) have also studied the 
consequences of infection with vhs 1. In the absence of vi-
ral polypeptide synthesis, cells infected with vhs 1 showed 
no decay of several host mRNAs including P-actin, a-tubulin, 
or heat shock protein 70. In contrast, cells infected with 
wild type virus under the same conditions rapidly degraded 
these messages. Likewise, a mRNAs were more stable in vhs 1 
infected cells, compared to wild type infected cells. While 
mRNA half-lives were not obtained, these results again indi-
15 
cate that the vhs function does not discriminate mRNAs. 
A hint as to the genetic locus of the vhs gene came from 
early studies by Fenwick et al. (54). Here, they document 
that HSV-2 causes a more rapid host shutoff than HSV-1. 
Therefore, by analyzing the shutoff characteristics of HSV-1 
x HSV-2 intertypic recombinants, they were able to map this 
function to between map units 0.52 and 0.59 on the HSV-2 ge-
nome. The isolation of vhs 1, an HSV-1 mutant (160) allowed 
the use of marker rescue to map the mutation. In marker res-
cue, intact mutant virus DNA is co-transf ected with known 
fragments of the wild type genome into permissive cells. The 
resulting progeny virus are then screened for wild type shut-
off activity. Kwong et al. ( 108} also exploited the fact 
that vhs 1 grows somewhat slower in culture than its wild 
type counterpart. This allowed the enrichment of recombi-
nants before screening. The end result was that a 265 base 
pair fragment spanning from 0.604 to 0.606 on the wild type 
HSV-1 genome rescued the mutation in vhs 1. Examination of 
the viral genome sequence in this region implicates an open 
reading frame designated UL41 that encodes a protein with an 
apparent molecular weight of 58,000 daltons and a predicted 
molecular weight of 54,914 daltons (126). A 1.6 kb intron-
less mRNA is derived from that region, and it is regulated as 
a -yl gene (60). 
16 
Inhibition of Host Translation in Other Viral Systems 
Although infection of a host cell by a virus frequently 
results in gross alterations in the translation pattern in 
the infected cell, the method used by HSV, namely the active 
degradation of host mRNA, is seldom found in other viruses. 
Indeed, the function is not essential to the growth of HSV in 
culture (160). Kozak (102) proposes several mechanisms 
whereby a virus can usurp the translational machinery of an 
infected cell. The first, and conceptually most straightfor-
ward, is competition of viral and cellular mRNAs for the 
same, unaltered cellular translational machinery. 
This competition can occur in several ways. The virus 
may simply overwhelm the translational capacity of the host 
with so many copies of viral mRNAs that host mRNA becomes the 
minority species in the cell. Or, the viral mRNA may be more 
efficiently translated than host message. The competing host 
mRNA can also be eliminated by degradation. Any of these 
modes may also be involved in the switch from early to late 
viral protein synthesis that occurs in many viruses. In 
effect, the late viral mRNAs are competing with early mes-
sages for translation. 
The second method for preferential translation of viral 
mRNAs is to alter the normal translational apparatus by in-
activating a component necessary for translation of host mRNA 
but not required for viral mRNA translation. The third 
method also involves altering the translational apparatus, in 
17 
this case by production of a viral inhibitor of host mRNA 
translation. This method is complicated by having to invoke 
mechanisms whereby the viral mRNAs bypass this inhibition. 
The final method involves the production of a viral factor 
that preferentially fosters the translation of viral mRNAs. 
The available evidence supports the idea that the vast 
majority of viruses use the first mechanism, that of compe-
tition, described above to preferentially translate their 
mRNAs. For instance, vesicular stomatitis virus (VSV) mRNA 
is as efficient as host mRNA for translation, but the sheer 
number of viral transcripts favors the production of VSV pro-
teins (119). Vaccinia virus, a member of the poxvirus fam-
ily, induces the active degradation of host cell mRNA (162). 
By eliminating the competition, vaccinia virus mRNA is pre-
ferentially translated. Influenza virus also degrades host 
mRNA (85). This is coupled with a high efficiency of in 
vitro translation of influenza mRNAs, making these mRNAs very 
competitive in the host cell. 
As described above, herpes simplex virus degrades not 
only host cell mRNA but also viral mRNA of the various ki-
netic classes (143,144,184). The initial degradation of host 
mRNA apparently allows for efficient translation of viral a 
mRNAs, while the degradation of early viral mRNAs allows late 
mRNAs to be translated. This nonspecific vhs-induced mRNA 
degradation coupled with specific transcriptional control 
thus regulates the levels of mRNA in cells infected with wild 
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type HSV. The virus does not require this degradation activ-
ity in culture (160), but it does provide the virus with a 
growth advantage {108). 
Poliovirus offers the only definitive example of the 
second method for preferential translation of viral mRNAs, as 
described above. This method, in which a cellular function 
necessary for the translation of host mRNA is altered by the 
infecting virus, is accomplished in poliovirus by the cleav-
age of a 220 kilodalton (kda) protein designated p220 (50). 
This protein is thought to be a part of a cellular initiation 
factor that binds to the 5' cap structure found on most eu-
karyotic mRNAs. Poliovirus mRNA lacks this 5' cap (57), and 
does not require the cap binding initiation factor. Pel-
letier and Sonenberg (149,150) recently showed that initia-
tion of translation of poliovirus mRNA occurs by ribosomal 
binding to internal 5' noncoding regions, obviating the need 
for a cap binding initiation factor. 
A difficult to classify mechanism is present in cells 
infected with adenovirus. Late in infection, viral tran-
scripts are preferentially translated even though host mes-
sage is present in undegraded form (154). Translation pro-
ceeds in these cells because an interferon-induced inactiva-
tion of eukaryotic initiation factor eIF2a is blocked by a 
virus associated RNA called VA RNA I (187,195). VA RNA I 
apparently binds a 68 kda cellular protein kinase, thereby 
blocking its autophosphorylation. The phosphorylated form of 
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the protein kinase normally phosphorylates eIF2a in response 
to the liberation of interferon, which leads to the inactiva-
tion of this necessary initiation factor. What this means is 
that the generation of interferon, a cellular response to 
adenovirus infection, leads to the shutoff of translation. A 
viral response, namely the production of VA RNA I, restores 
translation by preventing this interferon-mediated shutoff 
(98). What remains to be defined is how the active form of 
eIF2a interacts specifically with adenovirus transcripts to 
allow their preferential translation, while host cell tran-
scripts are still apparently under the influence of the inac-
tivated eIF2a. Kozak suggests that this may again be a con-
sequence of effective competition of the viral transcripts 
for a limited amount of active translational machinery in the 
cell, that is, that VA RNA I is capable of blocking the inac-
tivation of only a fraction of the total pool of eIF2a which 
is then available to translate the more efficient or more 
abundant viral mRNA. Obviously, much more work remains to be 
done to resolve this issue. 
No definitive examples of the other mechanisms for ef-
fecting viral translation in infected cells have yet been 
described. Therefore, the examples cited above suggest that 
viruses have a limited arsenal of weapons with which to at-
tack the host cell translational machinery. Most likely, the 
infecting virus overwhelms the cellular macromolecular syn-
thetic capacity to produce progeny virus. Occasionally, the 
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virus may have an active component to effect this takeover, 
such as the degradation of cellular mRNA. This makes the 
study of these active mechanisms most interesting, to help 
understand viral mechanisms of infection as well as cellular 
responses to that infection. 
stability of mRNA in Eukaryotic Cells 
Gene expression in eukaryotic cells can be regulated at 
many levels. This regulation can occur at several stages in 
the maturation and translation of the mRNA. Events such as 
the post-transcriptional processing of the nascent tran-
script, transport of the mature transcript to the cytoplasm, 
or the ability of that transcript to participate in transla-
tion, can all be regulated (137). The most straightforward 
way to regulate the expression of a gene is to either produce 
functional mRNA from that gene, or not (i. e., transcrip-
tional regulation) • Obviously, there are many subtleties 
involved in transcriptional regulation, but the end result is 
still the same: either a transcript is produced (at some 
level), or its production ceases. By and large, prokaryotic 
gene expression is controlled at the level of transcription, 
owing to the extremely short half-lives of most bacterial 
mRNAs (101). 
Transcriptional regulation may not be as effective in 
down-regulating gene expression in eukaryotic cells, espe-
cially when the gene encodes a long-lived mRNA as are found 
in these cells (173). 
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Such long messenger half-lives mean 
that terminating transcription does not halt the expression 
of a gene. The mRNA for that gene will perhaps exist through 
an entire cell cycle, far too long for effective control of 
gene expression. Hence, most control occurs at the post-
transcriptional level. This broad category covers many 
mechanisms that regulate the production of the polypeptide 
endproduct of the gene. One such mechanism is to prevent the 
transcripts from interacting with ribosomes, a process termed 
translational control. Another way of controlling gene ex-
pression post-transcriptionally is to degrade the transcript 
before it has a chance to interact with the translational 
machinery. This type of control, by regulating the degrada-
tion of mRNA, will be the focus of this section. 
Several hormones have been shown to act as external 
stimulants that regulate the degradation of specific mRNAs. 
Estrogen, for example, greatly increases the half-life of 
vitellogenin mRNA (26). Prolactin has the same effect on ca-
sein message, increasing its stability some 20-fold (75). 
Human growth hormone message is stabilized in response to 
glucocorticoid stimulation (145). This list is expected to 
grow, as cellular responses to hormone stimulation continue 
to be studied. How hormones regulate mRNA stability is as 
yet unknown. 
The stability of mRNA can also be regulated by cis-
acting sequences that have been found in several transcripts. 
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Transferrin receptor mRNA, for instance, responds negatively 
to increases in intracellular concentrations of iron (132). 
A sequence that can form a stem-loop structure in the 3' un-
translated region of that message has been implicated in this 
control. Apparently, increases in iron concentrations reduce 
the affinity of an mRNA binding protein for this 3' stem-loop 
sequence, and this in turn decreases the stability of trans-
ferrin receptor mRNA (133,177). Evidently, the mRNA binding 
protein protects the stem-loop from attack by endogenous 
ribonucleases. Histone mRNA also has a 3' sequence that can 
form a stem-loop structure, whose presence is required to 
couple the decline in histone mRNA levels to the decline in 
DNA synthesis (113). This stem-loop structure appears to be 
the target of nucleolytic attack both in vitro ( 17 4, see 
below) and in vivo (176). 
The 5' untranslated region of mRNA has been implicated 
in affecting the stability of mRNA encoding the proto-onco-
gene c-myc (155,159). A large stem-loop structure is present 
in the first exon, which is often translocated in transformed 
cells carrying an activated c-myc (183). The loss of this 
cis-acting structure may affect the binding of some regula-
tory protein, leading to a change in the stability of the c-
myc message. 
The mRNA structure most often implicated in the control 
of message stability is the 3' end, and its associated 
poly(A) tail, a feature present on most eukaryotic messages 
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(22)• The poly(A) tail does not exist free in the cell, but 
rather is complexed with a ribonucleoprotein known as the 
poly(A) binding protein (see below). This poly(A)-poly(A) 
binding protein complex is thought to be a major determinant 
of mRNA stability, as studied both in vivo and in vitro. 
Some early work on the role of the poly(A) tail involved 
injecting globin mRNA with poly(A) tracts of various lengths 
into Xenopus oocytes (140). Globin mRNA with poly(A) tracts 
of 32 residues could direct translation as efficiently as 
mRNA with 150 residues. Messages with 16 or less adenylate 
residues in their poly(A) tails were ten-fold less efficient, 
at a level comparable to deadenylated mRNA. The deadenylated 
mRNA molecules were rapidly degraded in the Xenopus oocytes, 
while mRNA molecules with normal poly(A) tails were stable. 
This work suggests that some minimum length of poly(A) 
tail is required for a given message to remain functionally 
active. Likewise, the poly(A) binding protein requires a 
minimum length of about 27 residues for efficient binding. 
This minimum length requirement may explain why globin mRNA 
is rapidly degraded if the poly (A) tail is less than 16 
residues long, and may explain data concerning the poly(A) 
tail of metallothionein mRNA. When newly synthesized, this 
mRNA has a poly(A) tail of about 200 residues; over the next 
ten hours, the length of this tail decreases to about 3 o 
residues (127). Subsequently, the steady-state level of this 
mRNA declines. The simplest explanation for these data is 
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that mRNA molecules with 30 or fewer residues lack a poly(A) 
binding protein, and are rapidly degraded, leading to a 
decline in the steady-state level. In fact, two separate 
reports, one on c-~ and the other on c-fos, indicate that 
the first step in the degradation of these two mRNA species 
is the nucleolytic attack of the poly(A) tail, followed by 
rapid degradation of the body of the mRNA in a 3' to 5' 
direction (24, 226). 
A conserved 3' AU-rich sequence has been identified in 
these and other short-lived messages. This sequence has been 
found in the 3' untranslated regions of the granulocyte mono-
cyte-colony stimulating factor (GM-CSF;l93), the proto-onco-
gene c-myc (96), and the proto-oncogene c-fos (226). Several 
investigators have suggested a link between alteration of the 
stabilities of these messages and subsequent cellular onco-
genic transformation (112,114,148,188). Indeed, the removal 
of a 3' noncoding region containing this AU-rich sequence 
from the c-fos proto-oncogene makes the resulting transcript 
much more stable (226). Conversely, the addition of this 
sequence to the 3' end of the normally stable P-globin mRNA 
makes the chimeric message relatively unstable (211). 
Two facts, therefore, emerge. One is that, in the case 
of c-myc and c-fos, the degradation of these messages is pre-
ceded by the rapid removal of their poly (A) tails. The 
second fact is that both of these messages contain a con-
served AU-rich sequence in their 3' untranslated regions. 
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one proposed model to account for these facts involves postu-
lating that the affinity of the poly(A} binding protein for 
the poly(A} tail is influenced by the AU-rich region, which 
might expose the poly(A} tail to attack by endogenous nucle-
ases (18). 
Additional work in vitro supports this hypothesis. Ross 
and colleagues have developed and exploited an in vitro 
system derived from the polysomes of K562 cells, a human 
erythroleukemia cell line (174). Initial studies with this 
system involved analysis of histone mRNA, a class of message 
that normally lacks a poly(A} tail, which is tightly regu-
lated with respect to the cell cycle (189). Histone message 
is barely detectable during G1 phase, accumulates during s 
phase, and is rapidly degraded at the end of S phase. His-
tone mRNA, when microinjected into Xenopus oocytes, is de-
graded rapidly; the addition of a poly(A} tail increases its 
stability (84). Likewise, the addition of a poly(A} tail to 
histone mRNA stabilizes it 10 to 20-fold in vitro (151). The 
degradation of normal nonpolyadenylated histone mRNA com-
mences at a 3' stem-loop sequence, and proceeds from 3' to 5' 
(174). The addition of a poly(A} tail may protect the 3' 
stem-loop from this degradation, leading to this increase in 
stability. 
The degradation of c-myc mRNA was examined in this same 
.in vitro system. This species of mRNA has a poly(A} tail, 
unlike normal histone mRNA, but it is rapidly degraded (see 
above)• 
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Incubation of this mRNA in vitro showed that the 
poly(A) tail was removed prior to nuclease attack on the 3' 
untranslated region of c-myc mRNA (24). The poly(A) tail of 
p-globin mRNA, a long-lived message, was unaffected under the 
same conditions. 
A paradox emerges from these in vitro data. on the one 
hand, the addition of a poly(A) tail to an otherwise unstable 
histone mRNA stabilizes it; likewise, the stable P-globin 
mRNA remains so in vitro. On the other hand, a normally 
polyadenylated mRNA like c-myc is highly unstable in this in 
vitro system, mimicking its in vivo instability. It would 
seem that a poly(A) tail would behave in a like manner with 
respect to all messages, since there are no sequence differ-
ences that would influence the specificity of poly(A)-spe-
cific nucleases. Therefore, the answer must lie elsewhere. 
one possible influencing factor is the poly(A) binding pro-
tein (PABP). 
The biochemistry and genetics of the PABP are discussed 
extensively in the next section. This discussion will focus 
on the role of the PABP in stabilizing mRNA. Early data 
demonstrated that a protein-free poly(A) tail is much more 
sensitive to snake venom exonuclease than a PABP-bound 
poly(A) tail (16). Ross and coworkers examined the role of 
the PABP on the long half-life of /j-globin mRNA in vitro 
(17). In the first series of experiments, in vitro synthe-
sized p-globin mRNA was incubated in the cell-free system 
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along with a ribosomal salt wash (this provides PABP and 
nucleases). When competitor poly(A) was present in the 
reaction mix, the rate of decay of the P-globin target was 
seven-fold greater than when the competitor was absent. The 
addition of poly(G), poly(U), or poly(C) had no such effect 
on the rate of P-globin mRNA degradation. It is conceivable 
that the competitor poly(A) binds the free PABP, leaving the 
poly(A) tails of the P-globin mRNA accessible to nucleolytic 
attack. Therefore, the presence or absence of PABP on the 
poly(A) tails of P-globin mRNA may determine the stability of 
the message. 
This hypothesis was examined by looking at the stability 
of the P-globin transcripts in a cell-free extract whose 
ribosomal salt wash was depleted of free PABP by prior pas-
sage of the salt washes through a poly(A)-Sepharose column. 
The rate of p-globin mRNA degradation was seven-fold higher 
when treated ribosomal salt wash was added to the cell-free 
system. This degradation is characterized by removal of the 
poly(A) tail prior to sequential 3' to 5' digestion of the 
body of the p-globin mRNA. Addition of purified PABP to this 
system increased the stability of this mRNA, while addition 
of purified PABP had no effect on the decay rate of histone 
mRNA or on deadenylated P-globin mRNA. 
Hence, the PABP-poly (A) complex appears to regulate 
message half-life, at least in vitro. This partially satis-
fies the hypothesis concerning the 3' AU-rich sequence found 
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in many short-lived messages, as discussed earlier. This 
hypothesis involves an alteration in the affinity of the PABP 
for the poly (A} tail of these transcripts by the AU-rich 
sequence. This AU-rich sequence may bind a regulatory pro-
tein that decreases the affinity of the PABP for the poly(A} 
tail. The migration of the PABP off these poly(A} tails may 
allow endogenous nucleases to attack the poly(A} tail, initi-
ating the progressive 3' to 5' degradation of these messages 
(18}. What remains is the examination of the affinity of the 
PABP on the poly(A} tails of various messages, with and with-
out the 3' AU-rich sequence. 
The study of the degradation of tubulin mRNA suggests 
that the stimulus for degradation may not reside in the RNA 
sequence itself. Tubulin is the predominant subunit of 
eukaryotic microtubules (37}. Tubulin mRNA has long thought 
to be autoregulated; drugs that increase the levels of free 
tubulin in the cell (e. g. colchicine and nocodazole} de-
crease synthesis of new tubulin, while drugs that decrease 
the amounts of free tubulin (e.g. vinblastine and taxol} in-
crease tubulin synthesis (14,32,38}. The direct microinjec-
tion of purified tubulin into cells has the same effect as 
drugs that increase the concentration of free tubulin, that 
is, to rapidly inhibit tubulin synthesis (39). 
This inhibition occurs at the level of mRNA stability 
rather than at the transcriptional level. Enucleated cells 
react to the drugs mentioned above in the same way as intact 
cells (156}. 
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Furthermore, alterations in the synthesis of 
tubulin in response to the various drugs were matched with 
alterations in the levels of tubulin mRNA (33). Lastly, a 
hybrid gene construct, with the tubulin promoter being re-
placed with a metallothionein promoter, was still autoregu-
lated (63). These data all suggest that the autoregulation 
of tubulin synthesis is specified by directed regulation of 
the stability of tubulin mRNA. 
Transfection experiments using a hybrid tubulin/thymi-
dine kinase gene showed that the first 13 nucleotides of the 
coding region of tubulin mRNA were necessary and sufficient 
for this autoregulated message instability (228}. Tran-
scripts derived from a variety of in vitro mutagenized tubu-
lin genes showed that mutations (either point or frameshift} 
that changed the amino acid sequence of the first four amino 
acids abolished autoregulation of these transcripts; changes 
in the third nucleotide of each codon were tolerated if they 
resulted in conservative replacements of the amino acids 
(229}. Likewise, relocation of these 13 nucleotide to an 
internal position of the transcript abrogated the autoregu-
lated control. 
The novel suggestion is that the autoregulated degrada-
tion centers on the first four amino acids of the nascent 
polypeptide rather than on a nucleotide sequence of the 
transcript. A model has been proposed to explain these 
observations (228). As levels of free tubulin increase in 
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the cell, the autoregulatory protein (presumably the free 
tubulin) binds to these first four amino acids of the nascent 
polypeptide chain. This protein-nascent protein interaction 
somehow triggers the degradation of the presently translating 
tubulin mRNA. This could either be by activating a specific 
nuclease, or by causing the ribosomes to pause, thereby 
exposing transcripts to attack by endogenous nucleases. In 
either case, this hypothesis is different from the others 
described above in that the target of the ribonucleases 
appears to be actively translating mRNA. The mechanism of 
ribonuclease-mediated mRNA degradation may, however, be very 
similar in all of the systems described. 
Ribonucleoprotein Particles: A Review of the Literature 
In all known cells information passes from deoxyribonu-
cleic acid (DNA) 
intermediate (4). 
to protein via a ribonucleic acid (RNA) 
In eukaryotic cells, the primary RNA 
transcript is known as heterogeneous nuclear RNA (hnRNA), 
and, as its name implies, it is found in the nucleus. The 
hnRNA is modified in several ways before it is termed mRNA. 
Most hnRNA contains intervening sequences (introns) that are 
subsequently spliced out. The hnRNA has a cap structure 
added to its 5' end and a polyadenosine [poly (A)] tail added 
to its 3' end. The end product of these reactions is mRNA, 
and it is found in the cytoplasm (137). Neither type of RNA 
exists naked in the cell. Rather, the RNA is associated with 
31 
protein in a complex structure called a ribonucleoprotein 
particle (RNP} • This discussion will focus on the RNPs 
derived from hnRNA and mRNA, called hnRNP and mRNP (reviewed 
in 48,122} . The existence of these RNA-protein structures 
has been widely debated, but recent experiments eliminated 
any doubt that such structures are found in vivo. 
The earliest evidence for the existence of mRNPs came 
from Spirin and coworkers in 1964 (reviewed in 200). They 
established the criteria used for mRNP identification that 
lasted for the following decade. Essentially, the technique 
involved pulse-labeling cells with radioactive RNA precur-
sors, then passing the cytoplasm over a sucrose gradient to 
isolate the labeled material. This material is then fixed 
with formaldehyde and analyzed by isopycnic centrifugation in 
a CsCl gradient. The fixed material was found to have a 
buoyant density between 1.35 g/cm3 and 1.5 g/cm3 • By compar-
ison, free RNA has a buoyant density of about 1.9 g/cm3 and 
ribosomes band at 1. 55 g/cm3 • Spirin suggested that the 
fixed material was a complex of protein and RNA (201). 
Other workers (78,95,125) at the time believed these 
RNA-protein complexes to be what are today called initiation 
complexes, mRNA in association with the 40S ribosomal sub-
unit. Their error was in analyzing only a portion of the 
sucrose gradient; Spirin and coworkers analyzed both subribo-
somal and postpolysomal fractions for mRNP structures (201). 
Henshaw and Loebenstein confirmed this work, but raised the 
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"possibility that the complexes of polydisperse RNA with 
protein are an artifact of homogenization" (79). 
This caveat led to the development of a variety of 
isolation protocols designed to control for such artifacts. 
Blobel (20) isolated mRNPs from dissociated rabbit reticulo-
cyte ribosomes in the presence of 500 mM KCl; presumably, the 
high salt would discourage any nonspecific interactions and 
lead to the identification of mRNA-specific proteins. He 
demonstrated the existence of two proteins, one with an 
apparent molecular weight of 52 kda and the other, 78 kda. 
Greenberg (70) isolated unfixed mRNPs from mouse L cells on 
cesium sulfate density gradients, arguing that this isolation 
protocol would serve to remove all but the most tightly bound 
proteins. This procedure yielded a more complex protein pro-
file, but did show the presence of a 76 kda protein he felt 
corresponded to the 78 kda protein demonstrated by Blobel. 
Other workers, using isotonic isolation procedures, also 
showed complex protein profiles, but all showed proteins of 
about 78 kda and 50 kda (8,62,207). 
Blobel (21) is credited with the next breakthrough in 
the field. He demonstrated that the 78 kda protein isolated 
by his high salt protocol was associated with the poly(A) 
tail of polysomal RNA. In these experiments, L cells were 
incubated with either [3H]adenosine or [ 3H]uridine, and mRNPs 
were isolated from dissociated polysomes. After selective 
digestion with pancreatic ribonuclease (RNase) and RNase Tl, 
33 
which leaves poly (A) tails intact, the digestion products 
were separated on sucrose gradients. The 78 kda protein was 
shown to be associated with an 11S [3H]adenosine peak, where-
as [ 3H]uridine was evenly distributed throughout the gradi-
ent. Base composition analysis showed approximately 80% AMP 
in the peak associated with the 78 kda protein. Kwan and 
Brawerman (106) repeated the same experiment with mouse 
sarcoma 180 ascites cells and obtained similar results. 
More definitive demonstrations followed upon the devel-
opment of a new technique using oligo(dT)-cellulose to iso-
late mRNA that contains a poly(A) tail (5). This allowed 
investigators to separate polyadenylated mRNPs, as well as 
the poly(A) tail itself, free from contaminating fragments. 
Lindberg and Sundquist (115) were the first to develop a 
technique for isolating mRNPs on oligo(dT)-cellulose. The 
eluted material was shown to be mRNP by the buoyant density 
criterion established by Spirin ten years earlier (201). The 
protein composition of this material was examined by labeling 
KB cells with [ 35S]methionine, isolating the mRNPs on oligo-
(dT) -cellulose, and resolving the proteins on polyacrylamide 
gels. KB cells were shown to contain four mRNP proteins of 
apparent molecular weights of 125 kda, 78 kda, 68 kda, and 56 
kda. The isolation was done in the presence of moderate salt 
concentrations, suggesting the RNA-protein interactions were 
specific. 
Other investigators used this new procedure to isolate 
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mRNPs from various cell types, all reporting a variety of 
protein components (86, 91,207). Again, the presence of the 
poly(A) binding protein of about 72 kda and a protein of 
about 50 kda were consistently present. No other pattern of 
proteins emerged from this work. This suggested that most of 
these proteins were artifacts of the isolation procedure 
used, and were not true mRNP proteins associated with mRNA in 
vivo. An observation by Smith (197) in 1969 suggested a way 
around this quandary. He showed that DNA could be efficient-
ly crosslinked to amino acids with ultraviolet (UV} light. 
Indeed, the interaction was such that only molecules in close 
association with the nucleic acid would be covalently at-
tached. Greenberg (71} adapted this finding to be used in 
the isolation of mRNPs by exposing polysomes to UV light and 
isolating the resulting covalent complexes under more strin-
gent conditions. 
setyono and Greenberg (192} identified six major protein 
components of polysomal mRNPs UV crosslinked in this manner. 
The mRNP material, isolated on oligo(dT}-cellulose, contained 
proteins of 98 kda, 78 kda, 75 kda, 68 kda, 62 kda, and 52 
kda. That the 78 kda protein associated with the poly(A} 
tail was confirmed by digesting the UV crosslinked mRNPs with 
RNases A and Tl in high salt, and chromatographing the diges-
tion products through oligo(dT}-cellulose. This procedure 
should leave the poly(A} tail and its crosslinked proteins 
bound to the column, while other RNA fragments and proteins 
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flow through. Upon elution of the poly(A) tail with a low 
salt buffer, the remaining RNA was digested with micrococcal 
nuclease (a nonspecific nuclease) and the proteins analyzed 
on a polyacrylamide gel. Prior labeling of the proteins with 
[ 35s )methionine allowed autoradiography of the gel; a single 
protein of 78 kda was detected. 
The UV crosslinking procedure Greenberg and colleagues 
used was still open to artifacts, since the crosslinking took 
place after lysis of the cells. To eliminate the risk of 
nonspecific protein interactions occurring during the isola-
tion procedure, Wagenmakers et al- (220) developed the tech-
nique of irradiating intact living cells with UV light, then 
isolating the mRNP complexes in the presence of 2-mercapto-
ethanol, sodium dodecylsulfate, and at elevated temperatures 
(90°C) to discourage any nonspecific protein binding. After 
isolating the mRNPs on oligo(dT)-cellulose, the RNA moiety of 
the mRNP was digested with a mixture of RNase A and micrococ-
cal nuclease and the [35S]methionine-labeled proteins were 
resolved on polyacrylamide gels. Prominent bands were found 
at 73 kda, 69 kda, and 52 kda; several minor bands of varying 
intensity were also noted. Unirradiated controls showed no 
protein bands when isolated under identical conditions. 
Adam et al. (1), using a similar protocol, identified a 
larger set of proteins crosslinked to the mRNA of HeLa cells. 
They showed polypeptides of 135 kda, 93 kda, 72 kda, 68 kda, 
53 kda, 50 kda, 43 kda, and 36 kda. The major proteins 
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banded at 72 kda, 68 kda, 53 kda, 50 kda, and 36 kda. The 72 
kda protein was shown to be the poly(A) binding protein. 
very little is known about the function of these pro-
teins, although the locations on the mRNA of several proteins 
is known. The 72 kda protein is known to bind to the poly(A) 
tail (1,21), while several others bind to the 5' cap struc-
ture (72). The 50 kda major mRNP protein has been reported 
to associate with both the 5' cap structure and the body of 
the mRNA, but not with the poly(A) tail (72). Still, there 
is some speculation about the possible functions for these 
mRNP proteins. First, these proteins may serve to protect 
the mRNA from degradation by endogenous nucleases. Hence, 
the functional stability of the mRNA may be regulated by 
these proteins. Secondly, these proteins may participate in 
translation of the mRNA into protein, or conversely may serve 
to prevent the translation of certain messages. That is, 
these proteins may serve in translational control of eukary-
otic gene expression. Lastly, these proteins may serve a 
transport role, moving the mRNA from the nucleus into the 
cytoplasm and ultimately to the ribosomal subunits for trans-
lation (23). Clearly, these functions are not mutually 
exclusive, and may not even be separable. The function of at 
least certain proteins in hnRNP particles is in splicing 
(35) • 
As mentioned earlier, the poly(A) binding protein is the 
best characterized of all the known mRNP proteins. Several 
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functions have been suggested for this protein. Schwartz and 
oarnell ( 190) suggested that the protein in HeLa cells is 
involved in transport from the nucleus to the cytoplasm, but 
this observation has not been confirmed. Van Venrooij et al. 
(216) suggested that "free" mRNA (i.e., that mRNA not asso-
ciated with the polysome fraction) lacked the poly(A) binding 
protein, although polysomal mRNA carried this protein. This 
implies that the poly(A) binding protein is involved in 
translational control. Vincent et al. (217) showed that a 
variety of protein differences were found between free and 
polysomal globin mRNPs, including the lack of the poly (A) 
binding protein on free mRNPs. It was also shown that free 
mRNPs could not be translated in vitro, again strongly impli-
cating the poly(A) binding protein in translational control. 
Jacobsen and Favreau (90) showed that the addition of 
exogenous poly (A) tracts to in vitro translation extracts 
would, in a dose-dependent manner, inhibit the efficiency of 
translation of polyadenylated mRNA. This inhibition could be 
overcome by translating mRNPs instead of naked mRNAs, sug-
gesting that a protein component of the mRNPs was the rate-
limi ting factor. A group at the University of Stuttgart, 
extending the observation of van Venrooij et al. ( 216) , 
demonstrated that free globin mRNA lacked the poly(A) binding 
protein, but the protein could be found in mRNPs isolated 
from 48S initiation complexes as well as in polysomes (186). 
This group also extended the findings of Jacobsen and Favreau 
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(90), showing that homopolyribonucleotides other than poly(A) 
did not effect the efficiency of translation. Lastly, this 
group showed that in vitro translation extracts depleted of 
RNA binding proteins would not translate naked mRNA but would 
translate exogenous mRNPs. The naked mRNA could be trans-
lated if certain RNA binding proteins were added back (185). 
Munroe and Jacobson (134) examined a set of in vitro 
synthesized transcripts which differ only with respect to the 
lengths of their poly (A) tails. These transcripts were 
analyzed in in vitro translation reactions for their effi-
ciency of translation. Nonpolyadenylated mRNA was unable to 
be efficiently translated, even though it was no more unsta-
ble than identical polyadenylated transcripts. The authors 
discovered that this translational defect stemmed from a 
reduced capacity of nonpolyadenylated mRNA to form 80S initi-
ation complexes. The authors suggest that the presence of a 
poly(A) tail somehow influences events at the 5' end, enhanc-
ing the binding of an initiation factor or ribosomal subunit 
there. Jackson and Standart (87) speculate that this 3' in-
fluence over 5' events, which they term "cross-talk", may be 
the result of alternative secondary structures propagating at 
the 3' end, or may involve direct interaction between the 3' 
and 5' ends. These events are probably mediated by proteins 
such as the poly(A) binding protein and other mRNP proteins. 
Indeed, several investigators have demonstrated that 
naked mRNA, when added to an in vitro translation extract, 
39 
forms a structure indistinguishable from polysomal mRNPs 
isolated in vivo (61,73). Butcher and Arnstein (29) demon-
strated that rad.ioiodinated mRNPs could engage in efficient 
translation, and that the labeled proteins always remained 
associated with sos ribosomes and polysomes in vitro. All 
this evidence together strongly suggests that one or more 
protein components of mRNPs are involved in translation, and 
that the 3' poly(A) tail and its associated protein may be an 
important factor in enhancing the translation of mRNA. 
Another apparent function of the poly(A) binding protein 
is in the formation of a periodic structure of the poly(A) 
tail. The repeating structure of the poly(A) tail can be 
seen by mild digestion of poly (A) tails from mRNPs with 
nonspecific nucleases. The resulting RNA fragments range in 
size from about 15 to 150 adenosine residues, with a peri-
odicity of about 25 bases (6,99). This structural property 
of the poly(A) binding protein was used to purify a 75 kda 
protein from rat liver (7). All indications suggest this 75 
kda protein is identical to the poly(A) binding protein found 
tightly associated with mRNPs. These data suggest that the 
poly(A) binding protein induces a periodic structure in the 
poly(A) tail, in a manner similar to the periodic structure 
induced by histones in eukaryotic DNA (4). 
Rose et al. (170) reported that poly(A) polymerase and 
the poly(A) binding protein share related antigens. Poly-
clonal rabbit antibody was raised against poly(A) polymerase 
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isolated from rat hepatoma nuclei. Poly(A) binding protein 
isolated from HeLa cell polysomal mRNPs could compete for 
this antibody in a competitive radioimmunoassay to the same 
level as purified poly(A) polymerase, suggesting both mole-
cules share similar, if not identical, epitopes. That these 
are not the same proteins is evidenced by the different 
molecular weights of the proteins {60 kda for poly(A) poly-
merase and 72 kda for HeLa poly(A) binding protein) and the 
different cellular locations (nucleus for poly(A) polymerase 
and cytoplasm for poly(A) binding protein). 
More recent reports indicate that there may be several 
forms of poly {A) polymerase in HeLa cells. Ryner et al. 
(178) detected two forms of the enzyme in nuclear fractions 
and one form of the enzyme in cytoplasmic fractions. Each 
enzyme activity, when mixed with appropriate nuclear frac-
tions containing necessary cofactors, could catalyze the 
cleavage and polyadenylation of target pre-mRNA containing 
the canonical AAUAAA sequence (230). The three forms of 
poly(A) polymerase were also shown to be similar in size and 
immunochemical cross-reactivity, suggesting that these three 
enzyme activities are closely related or identical. Whether 
any of these multiple forms of poly (A) polymerase is iden-
tical to the poly(A) binding protein of hnRNPs, as proposed 
by Dreyfuss (48), remains to be ascertained. 
Recently, the gene for the poly(A) binding protein of 
the yeast Saccharomyces cerevisiae has been isolated and se-
guenced (3,179). 
principal regions. 
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The protein structure consists of two 
The N-terminal region consists of four 
homologous domains, each of which contains a short sequence 
conserved among several other RNA binding proteins. The c-
terminal region is rich in praline, glutamine, and alanine. 
To date, its function is unknown, although it may interact 
with other proteins to modulate the binding of the poly(A) 
binding protein to the poly(A) tail. Genetic analysis of the 
poly(A) binding protein gene showed that it is an essential 
gene in Saccharomyces (180). However, a yeast strain car-
rying a single N-terminal domain is viable. This suggests 
that the poly(A) binding function of the protein is critical 
to the cell. 
Another approach to examining the possible functions of 
mRNP proteins is by using viral systems to study both host 
and viral mRNP particles. The first study of mRNP structure 
in virus-infected cells was by Lindberg and Sundquist (115). 
They reported that KB cells infected with adenovirus type 2 
contained mRNPs that carried a novel 110 kda protein along 
with the other proteins found in uninfected cells. This 
finding was confirmed by another group (210,214); it must be 
noted that all groups used conventional mRNP isolation proce-
dures relying on isolation on sucrose gradients. When van 
Venrooij et al. (215) repeated this experiment using UV 
crosslinking, no such protein was found. They reported that 
the protein composition in infected cells was identical to 
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that of uninfected cells. In every report, mRNPs were iso-
lated at late times after infection. Hence, the lack of any 
difference as reported by van Venrooij et al.. could not be 
explained by a difference in time of isolation. Instead, 
other explanations must be forwarded. For example, the 
protein may not be efficiently crosslinked by UV light. Or 
the protein may interact with mRNP particles through protein-
protein interactions instead of directly with the mRNA. This 
latter possibility is likely because the labeling protocol 
used [3H]nucleosides to label the mRNA directly, in a label 
transfer protocol. After UV irradiation and RNase digestion, 
some of the labeled nucleosides remain covalently associated 
with the proteins to allow for detection by autoradiography. 
Adam and Dreyfuss {2) attempted to resolve this issue by 
using UV crosslinking with [ 35S)methionine labeling of pro-
teins, [ 3H]ribonucleoside labeling of RNA, and immunoblotting 
using antiserum against the adenovirus 110 kda protein. All 
analyses indicate that, at late times after infection, the 
110 kda protein was associated with both host and viral 
mRNAs. These mRNAs were also associated with the normal com-
plement of host cell RNP proteins, indicating that adenovirus 
infection does not lead to a dissociation of host mRNPs. 
Adam and Dreyfuss speculate that the contradictory results 
obtained by van Venrooij et al. stem from an inefficient 
infection of the host cells by the latter group. Adam and 
Dreyfuss cite results derived from abortive infection of CV-1 
r 
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cells, where the 110 kda protein was not crosslinked to mRNA, 
even though the protein was abundantly present in the in-
fected cells. 
The data concerning cells infected with vesicular sto-
matitis virus (VSV) is much more consistent when conventional 
versus UV crosslinking data is compared. VSV mRNA is tran-
scribed in the cytoplasm by a virally encoded RNA polymerase 
that is resistant to the effects of dactinomycin. As such, 
virus-specific message can easily be followed by infecting 
cells in the presence of 5 µg/ml dactinomycin (1). Grubman 
and Shafritz (74), using this protocol to label viral mRNP 
proteins with [35S]methionine, found that a 52 kda protein 
with a tryptic digestion pattern identical to the major 
virion nucleocapsid (N) protein was associated with isolated 
viral mRNPs. 
Cohen's group (171,172) confirmed this finding, but sug-
gested that viral mRNA was associated exclusively with N 
protein. They isolated polysomal mRNPs from VSV infected 
cells, identified the mRNA components as virus-specific by in 
vitro translation, and identified the protein component as N 
protein by metabolic labeling with [35S]methionine. Most sig-
nificant was their finding that viral mRNP particles could 
not be translated efficiently in vitro. This suggests that 
the mRNA is sequestered in vivo such that, although associat-
ed with polysomes, translation does not occur (171). Expan-
sion of this work suggested that formation of the ternary 
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complex was blocked in vitro by VSV mRNP or purified nucleo-
capsids, both of which contain N protein, and that this block 
could be overcome by the addition of excess eukaryotic initi-
ation factor eIF-2 (172). This result shows that VSV mRNP 
blocks translation by blocking the first step in initiation 
of translation. 
Dreyfuss' group (1) repeated the isolation of VSV mRNP 
using UV crosslinking. By label transfer using [3H]nucleo-
tide they showed that both host and VSV mRNA was associated 
with the same set of proteins. Both mRNPs also carried the 
72 kda poly(A) binding protein of HeLa cells on their poly(A) 
tails. To test if N protein was there but could not be 
resolved on the polyacrylamide gels, polyclonal antiserum was 
raised against purified VSV virions and used in Western blots 
of mRNP proteins. This experiment showed that the N protein 
was indeed there, but could not be seen because it co-mi-
grates with the 50 kda protein of uninfected HeLa cell mRNPs. 
In the case of VSV mRNPs, both conventional and UV cross-
linking protocols led to the same conclusion. 
The last report of a virus system used to examine mRNP 
proteins is one using herpes simplex virus. Bartkoski (10) 
analyzed the mRNP proteins of polysomal mRNAs in HEp-2 (human 
epithelial) cells infected with HSV type 1 (HSV-1). The 
protocol used involved the pelleting of polysomes in sucrose 
gradients, then labeling the mRNP proteins by radioiodination 
using lactoperoxidase. The polysomes were then dissociated 
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with EDTA and the mRNPs were isolated on oligo(dT)-cellulose 
colwnns. Upon polyacrylamide gel analysis, uninfected cells 
were shown to contain proteins of 74 kda and 52 kda, corre-
sponding to the molecular weights of known mRNP proteins, 
including the 74 kda poly(A) binding protein. At three hours 
post-infection, the mRNPS contained reduced levels of these 
two proteins but carried a new protein of 47 kda. By six 
hours post-infection, the 74 kda putative poly(A) binding 
protein was missing altogether, the 52 kda protein was mark-
edly reduced, and the 47 kda protein was abundant. 
These data are quite interesting and suggest that a 
radical change in the composition of mRNPs in HSV-1 infected 
cells takes place. However, the typical reservations remain 
about these data. First, the protein associations may be 
artifactual owing to the lysis protocol used. For instance, 
the number of mRNP proteins in uninfected cells reported here 
appears to be a subset of the total number of mRNP proteins 
reported by UV crosslinking experiments (48). Secondly, the 
radioiodination protocol may have led to inefficient labeling 
of the protein components of the mRNPs. Metabolic labeling 
is though to better label proteins, and may allow the dis-
tinction of cellular versus viral proteins in the mRNPs. 
Thirdly, only polysomal mRNPs were examined. The nature of 
free mRNPS in infected cells was not considered. By examin-
ing total cytoplasmic mRNPs, a broader picture of the events 
during infection could be obtained. Lastly, mutants such as 
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vhs 1 were not studied side by side with wild type virus, 
---
making the relevance of these earlier data uncertain. 
Proposed Studies in This Dissertation 
The focus of the experiments in this dissertation is to 
begin to elucidate the mechanism of regulation of mRNA sta-
bility mediated by the vhs function of herpes simplex virus. 
Initial experiments involve the use of marker rescue to begin 
to map the mutation in vhs 1. These studies involve the use 
of a cloned fragment of the wild type genome co-transfected 
with the intact vhs 1 genome. If the appropriate recombina-
tion events occur such that the defect in the vhs 1 genome is 
replaced with wild type sequences, then the resulting progeny 
virus should display wild type vhs activity. By using small-
er and smaller wild type fragments, the defect in the vhs 1 
genome could be mapped. 
Another set of experiments addresses the possible role 
of the proteins associated with mRNA in cells infected with 
herpes simplex virus. As discussed above, one role for these 
mRNP proteins is in the regulation of mRNA stability. By 
using a UV crosslinking protocol to deduce a definitive 
picture of the proteins associated with mRNA in cells infect-
ed with both wild type and vhs 1, it may be possible to 
determine if the vhs activity influences the structure of 
mRNPs. 
Another major avenue of experimentation centers on the 
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use of a cell-free system to study the rudiments of vhs-
mediated mRNA decay. The development of such a system would 
allow for a more detailed biochemical study of the vhs func-
tion, as well as opening up the possibility of a study of the 
broader question of mRNA stability in eukaryotic cells. The 
experiments described here involve the initial analysis of an 
in vitro mRNA degradation system mediated by the vhs func-
tion, and these experiments provide the basis for a discus-
sion of a model for vhs-mediated mRNA degradation. 
r 
MATERIALS AND METHODS 
Cells and Virus 
HeLa S3 and Vero cells were purchased from the American 
Type culture Collection {ATCC) and grown in Eagle's minimum 
essential medium {MEM; GIBCO) supplemented with antibiotics 
and 10% {vol/vol) calf serum. Stocks of wild type HSV-1, 
strain KOS, and the KOS-derived mutant yhs 1 were prepared 
from and titred on Vero cell monolayers as previously de-
scribed {143). In all experiments virus was allowed to ad-
sorb onto cell monolayers for one hour in MEM containing 5% 
calf serum. The inocula were then aspirated and the cells 
overlaid with fresh MEM plus 5% calf serum. Mock infected 
cells were treated in the same way, except that the cells 
were exposed to an uninfected Vero cell lysate prepared in 
the same way as the virus stocks. 
Plasmids 
The plasmid pSG124 {kindly provided by M. Levine) con-
tains the EcoRl fragment A {0.49 to 0.63 map units) of wild 
type HSV-1, strain KOS, inserted at the EcoRl site of pBR325 
{ 69) • The plasmid pHcGAP contains a 1. 2 kb cDNA insert 
encoding a portion of human glyceraldehyde-3-phosphate dehy-
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drogenase (GAPD), and was obtained from the ATCC. The plas-
mid pHSV106, which contains a 3.4 kb BamHl fragment encoding 
the HSV-1 thymidine kinase (TK), was purchased from Bethesda 
Research Laboratories. The plasmid pXlrll contains a 4.6 kb 
fragment of Xenopus laevis rDNA inserted into the EcoRl site 
of colicin El (42), and was kindly provided by J. Doering. 
The plasmids pSG124 and pXlrll were maintained in Escherichia 
goli strain HBl0l, while pHcGAP and pHSV106 were maintained 
in strain DH5a (Bethesda Research Laboratories). Plasmid DNA 
was prepared by ethidium bromide-CsCl density gradient cen-
trifugation as described previously (120). 
Transfection Procedures 
Two sets of transfections were carried out according to 
the protocol of Stow et al. (204). One set consisted of the 
intact vhs 1 DNA alone; the other set was a co-transfection 
of the intact viral DNA and pSG124 DNA digested with EcoRl. 
In either case, the procedure involved the following. First, 
approximately 4 x 106 Vero cells were seeded into a 25cm2 
flask containing 5 ml of MEM plus 5% calf serum at about 6 h 
prior to transfection to ensure a subconfluent monolayer of 
cells. To prepare the DNA for transfection, appropriate 
quantities of vhs 1 DNA with or without pSG124 DNA were 
resuspended in 1. o ml of Hank's buffered saline (HBS: per 
liter, 8.0 g NaCl, 0.37 g KCl, 0.125 g Na2HPO4•H20, 1.0 g dex-
trose, 5.0 g N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic 
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acid [HEPES; pH 7.05]). The final concentration of DNA was 
brought up to 20 µg/ml using salmon sperm carrier DNA. To 
this DNA mixture was added 75 µl of 2 M CaC12 to form a fine 
calcium phosphate precipitate. The precipitate was allowed 
to form for one hour. 
After formation of the precipitate, the medium was 
poured off the cells in the flasks, and 1.0 ml of precipitate 
was added and allowed to incubate at 34°C for 45 min. After 
45 min., the cells were overlaid with 5 ml fresh MEM plus 5% 
calf serum and allowed to incubate a further J h 45 min. At 
this point ( 4 h after the start of transf ection) the old 
medium was poured off and the cells were shocked with 25% 
dimethyl sulfoxide (DMSO) in HBS for 4 min. After the DMSO 
was removed, the cells were washed twice with 5 ml fresh MEM 
plus 5% calf serum, then the same was placed on the cells and 
incubation continued for about 5 more days, until cytopathic 
effect was observed. 
The viruses tested in this report were generated by 
using 5µg intact vhs 1 DNA, 2. 5 µg pSG124 digested with 
EcoRl, and 13. 5 µg carrier DNA. Progeny viruses from the 
transfections were recovered by one cycle of freeze-thawing 
the flasks followed by sonication in a bath sonicator. The 
progeny were titrated on Vero cells in 24-well trays, and 
single virus plaques were obtained by plaque-purification in 
96-well trays. 
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Recombinant screening 
Small stocks of plaque-purified viruses were grown on 
vero cells in 24-well trays at 34°C until cytopathic effects 
were extensive. These trays were then freeze-thawed three 
times, and the resulting lysates were used to assay vhs 
function (160). This assay was performed on Vero cells grown 
in 24-well trays. The old medium was aspirated from a well 
of cells, then the cells were infected with 400 µ1 of the 
prepared viral lysate in the presence of a final concentra-
tion of 5 µg/ml dactinomycin (Calbiochem). At the end of a 5 
h incubation, the infected cells were labeled with [35S]meth-
ionine (DuPont-NEN) for 1 h. The amount of radioactive 
counts incorporated into trichloroacetic acid-precipitable 
material was used as a measure of ongoing host translation. 
Wild type viral lysates and mock infected cell lysates were 
examined in the same way. 
Ultraviolet Light Irradiation~ mBHf Preparation 
HeLa cells were grown to subconfluent densities and 
radiolabeled for the intervals described in the text by 
exposing cells to MEM containing one-tenth the normal amount 
of methionine, 20 µCi/ml [ 35S]methionine (DuPont-NEN), and 5% 
calf serum. 
Ultraviolet light irradiation and mRNP isolation were 
performed essentially as described by Adam et al. (1). After 
labeling, cell monolayers were washed twice with ice-cold 
r 
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phosphate buffered saline (PBS}, then overlaid with the same 
buffer. The cells were then exposed for three min to a 30 
watt germicidal lamp (Sylvania G30T8} placed 4.5 cm from the 
monolayer surface. This provides a UV dose of approximately 
6.5 x 103 ergs/mm2, as measured by a model UVX Digital Radio-
meter (Ultra-Violet Products, San Gabriel, CA}. After irra-
diation, the cells were allowed to swell in ice-cold RSB (10 
mM Tris HCl, pH 7. 4; 10 DIM NaCl; 1. 5 DIM MgCl2} containing 
o.5% aprotinin (Sigma}, 1 µg/ml leupeptin (Sigma}, 1 µg/ml 
pepstatin (Sigma}, and 10 DIM vanadyl ribonucleoside complex 
(VRC; Bethesda Research Laboratories}. The cells were lysed 
by the addition of Triton x-100 (Bio-Rad} to 0.5%, Tween 40 
(Sigma} to 1%, and sodium deoxycholate (Calbiochem} to 0.5%. 
The cells were then homogenized by four passes through a 25-
gauge needle. The nuclei were pelleted by low speed cen-
trifugation, and the supernatant was considered the cytoplas-
mic fraction. 
This fraction was adjusted to 0.5% sos, 1% 2-mercapto-
ethanol, and 10 DIM ethylenediaminetetraacetic acid (EDTA}, 
heated to 65°C for five min, then chilled on ice. LiCl was 
added to 0.5 M, and the cytoplasmic material was mixed for 15 
min with 0.5 ml of oligo(dT}-cellulose (type 3; Collaborative 
Research} preequilibrated with binding buffer (10 DIM Tris 
HCl, pH 7.4; 0.5 M LiCl; 1 DIM EDTA; 0.5% SDS}. After mixing, 
the resin plus cytoplasm was poured into a column, and the 
flowthrough was reapplied to the resin twice. The column was 
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then extensively washed with at least 10 column volumes of 
binding buffer, then poly(A)+ mRNPs were eluted with 2.5 ml 
of elution buffer (10 mM Tris HCL, pH 7.4; 1 mM EOTA; 0.5% 
sos). The volume of the eluate was reduced with 2-butanol 
and the mRNPs were precipitated at -20°c overnight by the 
addition of one-tenth volume 3M NaOAc and three volumes of 
ethanol. 
The precipitate was recovered by a 15 min spin in a 
microcentrifuge, dried under vacuum for 15 min, then re-
suspended in a small volume of RNase buffer (10 mM Tris HCl, 
pH 7. 4; 1 mM CaC12), and digested at 37°C for 60 min with 25 
µ,g/ml RNase A (Sigma) and 400 U/ml micrococcal nuclease 
(Pharmacia). This reaction also contained 0.5% aprotinin, 1 
µ,g/ml leupeptin, and 1 µ,g/ml pepstatin to prevent proteoly-
sis. After digestion, the proteins were precipitated by 
storage at -20°c for at least two hours by adding LiCl to 
0.5M and three volumes of ethanol. 
Protein Gel Electrophoresis 
The proteins were recovered by a 15 min spin in a micro-
centrifuge, dried for 15 min, and were resuspended in sos 
sample buffer (125 mM Tris HCl, pH 6.8; 1% sos; 5% 2-mercap-
toethanol; 10% glycerol; bromophenol blue). Samples were 
boiled for three min, and the proteins were resolved by sos 
polyacrylamide gel electrophoresis. The running gel con-
tained 12% acrylamide, 0.3% OATD, and 0.1% sos in 0.375 M 
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Tris HCl, pH 9.1. The stacking gel was 4% acrylamide, 0.44% 
BIS, and 0.1% SOS in 0.125 M Tris HCl, pH 6.8. Following 
electrophoresis, the gels were fixed in 10% acetic acid-JO% 
methanol and treated with Entensify (DuPont-NEN) as directed 
by the manufacturer. Dried gels were exposed to Kodak X-AR 5 
film for fluorography. 
Cell-free Extracts 
cytoplasmic extracts for studying in vitro mRNA degra-
dation were prepared from infected or mock infected HeLa 
cells using a modification of the procedure described by 
Brown and colleagues for the preparation of in vitro trans-
lation extracts (27). At the indicated times post-infection, 
cells were washed twice with ice-cold wash solution (0.15 M 
sucrose, 33 :mM NH4Cl, 7 mM KCl, 4.5 mM Mg(OAc) 21 and 30 mM 
HEPES, pH 7 .4), then permeabilized by the addition of 300 
µg/ml lysolecithin (L-a-lysophosphitidyl choline; Sigma) in 
wash buffer to the cells for 60 s. The lysolecithin solution 
was removed, and the cells from one 100 mm dish were then 
scraped into 200 µ1 of standard reaction mix (0.1 M HEPES, pH 
7.4, 0.2 M NH4Cl, 20 mM Mg (OAc)i, 7 mM KCl, 1 mM dithio-
threitol, 1 mM ATP (dipotassium salt), 1 mM GTP (sodium 
salt), 40 µM of each of the 20 amino acids, 0.1 mM s-aden-
osylmethionine, 1 mM spermidine, 10 mM creatine phosphate 
(dipotassium salt), 40 units/ml creatine kinase, and 100 
units/ml placental ribonuclease inhibitor (RNasin; Promega), 
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and disrupted by 10 passages through a 25 gauge needle. The 
nuclei were removed by a low-speed spin and the cytoplasmic 
supernatant was kept on ice until ready to use. 
The extracts were incubated at J0°C for the times indi-
cated. A zero time point was taken just before the extracts 
were placed at the incubation temperature. Same volume 
aliquots were removed from each sample, and placed in an 
equal volume of urea buffer (7 M urea, 10 mM Tris HCl, pH 
7.9, 0.35 M NaCl, 10 mM EDTA, and 1% SOS} then extracted 
twice with phenol:chloroform and twice with chloroform, as 
previously described. RNA was precipitated at -20°c over-
night with 3 vol 95% EtOH. 
Polysome Preparation 
Polysomes were prepared using a modification of the pro-
cedure of Ross et al. (175). Cells were washed and treated 
with lysolecithin as before. After removal of the lysoleci-
thin, the cells from one 100 mm dish were scraped into 200 µl 
of buffer A (1 mM potassium acetate, 1.5 mM magnesium ace-
tate, 2 mM dithiothreitol, 10 mM Tris HCl (pH 7.6)). The 
cells were lysed by 10 passages through a 25-gauge needle, 
and nuclei were spun out by a low speed spin. The super-
natant derived from two 100 mm Petri dishes of cells was 
layered onto a 1 ml cushion of 30% (w/v) sucrose in buffer A. 
Polysomes were pelleted by spinning in the TLS 55 rotor 
(Beckman) at 25,000 rpm for 1 h. The supernatant was dis-
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carded and the pellet gently washed twice with buffer A. The 
pellet was then resuspended in standard reaction buff er. 
undissolved chunks were broken up by homogenizing the pellet 
through a 25-gauge needle. The polysomes were incubated at 
30°c as described above. 
The preparation of supernatant material for the "mix-
and-match" analysis of various polysomal supernatant and 
pellet combinations was essentially as described above. 
After pelleting polysomes as described above, both the pellet 
and entire supernatant were retained. Care was taken to 
measure the volume of the polysomal supernatant so that the 
components of the standard reaction mix were present in the 
correct proportions. Additions, if necessary, were done 
using concentrated stock solutions. The final sucrose con-
centration in these supernatants was approximately 10%, owing 
to the retained sucrose cushion. The appropriate supernatant 
fraction was then mixed with the appropriate polysomal pel-
let, and the pellet was resuspended by homogenization through 
a 25-gauge needle, as indicated above. 
carried out at 30°C as above. 
Extract Pretreatment 
Incubations were 
To test the sensitivity of the extracts to brief heat 
treatment, standard in vitro degradation reactions were heat-
ed at 90°C for 10 min, cooled to 4°C, and then analyzed for in 
vitro decay of mRNAs according to the standard protocol. To 
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test the sensitivity of the extracts to pretreatment with 
protease, standard extracts were supplemented with proteinase 
K (Sigma; Molecular Biology Grade) to a concentration of 1 
mg/ml, and incubated at 30°C for 30 min before analysis for 
in vitro mRNA degradation according to the standard protocol. 
To test the effect of pretreating the extracts with 
micrococcal nuclease, standard in vitro degradation reactions 
were supplemented with micrococcal nuclease (Pharmacia) to 
1000 U/ml and CaC12 to 1 mM, and then incubated at 30°C for 10 
min. Ethyleneglycol-bis(P-aminoethyl ether) N,N'-tetraacetic 
acid ( EGTA) was then added to 2 mM and the extracts were 
chilled on ice for 10 min. Deproteinized total cytoplasmic 
RNA from an equivalent number of uninfected HeLa cells was 
added to each reaction mixture, which was then incubated at 
30°C and analyzed according to the standard protocol. 
Preparation .Qf. Soluble Virion Extracts 
Virion extracts of both wild type HSV-1 and vhs 1 were 
performed essentially as described by Preston et al. (158). 
Virus was prepared from infected Vero cells as described 
above, and the viral stocks were clarified by brief centrif-
ugation in a table top centrifuge. The virus was then pel-
leted by centrifugation at 25,000 x g for two h, and the 
pellet was resuspended in 10 mM Tris (pH 7.5), 50 mM NaCl, 1 
mM EDTA, and NP-40 to a final concentration of 0.5%. The 
virus was incubated at 4°C for one h. Soluble supernatant 
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was prepared by centrifugation of the viral extract at 50,000 
x g for one h, and the supernatant was stored at -70°C until 
used. 
RNA Electrophoresis. Northern Blotting. and Hybridization 
RNA was separated by agarose gel electrophoresis as 
previously described (161). The RNA was recovered from 
ethanol by a 15 min spin at 16,000 x g at 4°C. The dried 
pellet was dissolved in a small volume of diethyl pyrocarbo-
nate (DEPC) treated H2O. Aliquots of the RNA were incubated 
in 1 M deionized glyoxal, 10 mM NaH2PO4, pH 7.0, and 50% DMSO 
for 60 min at 50°C. The RNA was size fractionated on a 1% 
agarose gel in 10 mM NaH2PO4, pH 7.0, at 115 V for three hours 
with constant buffer recirculation. 
The fractionated RNA was capillary blotted onto Nytran 
nylon filters (Schleicher and Schuell) as directed by the 
manufacturer. The blotting buffer used was lOX SSPE (lX SSPE 
is 0 .18 M NaCl, 10 mM NaH2PO4 (pH 7. 7) , 1 mM EDTA) • The dried 
filters were prehybridized for 1-2 h at 42°C with constant 
agitation, and hybridized for 12-20 h under the same condi-
tions, as directed. Prehybridization buffer consists of 50% 
deionized f ormamide, 5X Denhardt' s solution ( lX Denhardt' s 
contains 0.02% Ficoll, 0.02% polyvinylpyrollidone, and 0.02% 
BSA), 0.1% sos, 100 µg/ml denatured salmon sperm DNA, and 5X 
SSPE. Hybridization buffer is identical to prehybridization 
buff er except the former buff er contains 2. 5X Denhardt' s 
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solution instead of 5X Denhardt's solution as in the latter. 
The nick-translated probes were denatured by boiling for 10 
minutes, then chilled on ice briefly before being added to 
the hybridization buffer. Viral TK was probed with nick-
translated pHSV106, whereas cellular GAPD was detected with 
nick translated pHcGAP. Nick translated pXlrll was used to 
detect 28S rRNA. Nick translation kits were purchased from 
Bethesda Research Laboratories and used as directed by the 
manufacturer. 
Blot washing was done as previously described (143), 
with two 45 min washes with 2X SSPE and 0.4% sos at room 
temp, followed by two 15 min washes with 0.lX SSPE at 60°C. 
Moist filters were exposed to Kodak X-AR5 film with intensi-
fying screens. 
Ouantitation of mRNA Levels 
To quantitate the levels of host and viral mRNAs and of 
28S rRNA, autoradiograms from the Northern blots were scanned 
using a Gilford Response UV-VIS Spectrophotometer fitted with 
an autoradiogram holder for gel scanning. 
RESULTS 
The experiments described in this section concern at-
tempts to elucidate the mechanism by which the yhs function 
degrades host and viral mRNA. Initial experiments involved 
efforts at mapping the mutation in vhs 1, the best character-
ized of the vhs mutants originally described by Read and 
Frenkel (160). From a mechanistic point of view, it is 
important to map the mutation in vhs 1 in order to show 
whether the vhs function acts alone or requires ancillary 
viral functions which may also have been mutated in this 
virus. By rescuing the mutation in yhs 1 with a sufficiently 
small cloned fragment from the wild type genome, it is possi-
ble to demonstrate that the vhs function is required for 
shutoff of host and viral polypeptide synthesis. These 
analyses do not exclude other ancillary viral or cellular 
factors required for this shutoff, but the recognition of one 
such factor, the vhs function, provides an extremely useful 
starting point for the examination of the shutoff process. 
The second set of experiments involved the analysis of 
the protein components of infected cell mRNPs. One possible 
mechanism of vhs function is the alteration of cellular mRNP 
structure, making the mRNA moiety more susceptible to attack 
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bY ribonucleases. Experiments by Bartkoski (10) first de-
scribed changes in the protein components of mRNP in HSV-1 
infected cells. A major conclusion of that work was that the 
levels of poly(A) binding protein associated with mRNA iso-
lated from wild type infected cells was decreased relative to 
the amounts detected in uninfected cells. However, as de-
scribed above, the method used was open to artifacts, and 
there were no relevant mutants available for similar analy-
ses. The experiments described in this section employed a 
uv-crosslinking procedure first described by Greenberg (71) 
and modified by Dreyfuss (1), a procedure more resistant to 
artifactual RNA-protein interactions. Also, the mRNPs exam-
ined in these experiments derived from cells infected by both 
wild type and vhs 1 viruses. This allowed a determination of 
the effects of the vhs function on the proteins associated 
with mRNA in infected cells. 
The final series of experiments concerns the development 
of an in vitro mRNA degradation system to study the vhs 
function. The in vitro system consisted of cytoplasmic 
extracts from HeLa cells infected with either wild type HSV-1 
or the mutant yhs 1. The preparation of these extracts was a 
modification of a procedure for an in vitro translation sys-
tem first described by Brown et al. (27). The development of 
the in vitro degradation system described here should eventu-
ally allow a more detailed biochemical analysis of the vhs 
function to be undertaken, and may lead to a better under-
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standing of the process of mRNA degradation in mammalian 
cells. 
Marker Rescue of the Vhs i Mutation 
To map the vhs mutation, Vero cells grown in 25 cm2 
flasks were transfected according to the protocol of Stow et 
al. (204). The transfection mixes contained 5 µg intact vhs 
1 DNA, 2.5 µg plasmid pSG124, containing the EcoRl fragment A 
from wild type HSV-1 strain KOS, and 12. 5 µg salmon sperm 
carrier DNA. Control transfections contained 5 µg intact vhs 
1 DNA plus 15 µg carrier DNA. Progeny viruses were screened 
to determine the fraction exhibiting wild type vhs activity. 
This screening involved picking individual progeny virus 
plaques and expanding them into small stocks by infecting 
Vero cells in 24-well trays. One half of the virus from each 
well was used to infect a fresh well of cells in the presence 
of 5 µg dactinomycin per ml. These cultures were labeled 
with [ 35S]methionine from five to six h post-infection, and 
the amount of radioactivity incorporated into trichloroacetic 
acid (TCA) precipitable material was used as a measure of 
ongoing host translation (160). Host translation in mock 
infected cells as well as cells infected with wild type virus 
was also measured in the same way. This provided a base line 
value for wild type host shutoff, in order to compare the 
degree of shutoff of the progeny viruses derived from the 
transfections. 
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Measurement of radioactivity incorporated into TCA 
precipitable material provides the easiest method for screen-
ing large numbers of virus for vhs activity. However, it 
would be impractical to screen statistically significant 
numbers of progeny from independent transfections involving 
each of the EcoRl fragments of the viral DNA. Fortunately, 
earlier data suggested a region of the genome on which to 
focus. Many strains of HSV-2 induce a more rapid shutoff 
than HSV-1 strains. By examining HSV-1 x HSV-2 intertypic 
recombinants, Fenwick and coworkers were able to correlate 
the rapid HSV-2 shutoff with the presence within the recombi-
nant of a portion of the HSV-2 genome from between o.52 and 
0.59 map units {54). 
The experiments described below therefore used the 
plasmid pSG124, which contains the EcoRl fragment A {from 
0.49 to 0.63 map units) of wild type HSV-1 inserted into the 
EcoRl site of pBR325 {69). co-transfections consisted of a 
mixture of pSG124, intact vhs 1 viral DNA, and carrier; 
control transfections consisted of the vhs 1 DNA and carrier. 
The results of screening 380 progeny from the experimental 
transfection and 274 progeny from the control transfection 
are tabulated to show the number of virus for which the level 
of incorporation into TCA-preci_pitable material was an indi-
cated percentage of the mock infected level {Figure 2). The 
progeny from the transfection involving vhs 1 DNA plus car-
rier formed a distribution centered at 100%. In contrast, 
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Figure 2. Host Shutoff Activity of Progeny from Transfec-
tions. The number of progeny from each type of transfection 
at a particular percent of the mock transfection is shown as 
a vertical bar, with the total number of progeny indicated 
above the bar. The figure legend indicates which vertical 
bar corresponds to which type of transfection. The experi-
ment was performed as described in the text. 
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the control transfection proved to be mutants upon retesting 
(Table 1), indicating that none of the 274 control progeny 
were revertants. In contrast six of the 10 progeny from the 
experimental transfection proved to be wild type for vhs 
activity. Since the control experiment yielded no revertant 
progeny, these six progeny apparently represent authentic re-
combinant viruses, signifying a frequency of marker rescue of 
6/380, or 1.6 x 104 • 
These six recombinant progeny were next screened to see 
whether they were mutant or wild type with respect to the 
shutoff of a polypeptide synthesis. This involves the actual 
resolution of polypeptides on polyacrylamide gels, and subse-
quent identification of viral a polypeptides. Vero cells 
were infected with the recombinant progeny, along with wild 
type and vhs 1 controls. The infections were carried out for 
five h in the presence of 50 µg cycloheximide per ml. Infec-
tion in the presence of cycloheximide allows viral a mRNAs to 
be transcribed, but inhibits the synthesis of any polypep-
tides. After five h, the cycloheximide containing medium was 
removed and replaced with medium containing 5 µg dactinomycin 
per ml. This inhibits further transcription, but allows any 
existing mRNAs to be translated. The cultures were labeled 
with [35S]methionine at various times to assay the rates of 
ongoing a translation. 
In accord with previous results (143,160}, a polypeptide 
synthesis continued for significantly longer in vhs 1 in-
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Table 1 
Rescreening of Progeny from Transfections 
Primary 
Virus Screen Rescreen 
60 0.49 0.49, 0.50, 0.63, 0.47 
86 0.20 O.JJ, 0.39, 0.40, 0.27 
93 0.35 0.26, 0.40, 0.39, 0.30 
Vhs 1 108 0.30 0.20, 0.19, 0.33, 0.26 
plus 215 0.20 0.19, 0.21, 0.20, 0.19 
WT EcoRl A 291 o.so 0.24, 0.25, 0.33, 0.24 
----------
--------------- -------------------------------------
37 0.68 1.21, 1.37, 1.26, 1.13 
115 0.69 1.06, 1.07, 0.97, 0.96 
332 0.61 1.21, 0.88, 1.09, 0.89 
340 0.68 1.09, 1.03, 0.98, 1.01 
404 0.63 1.03, 1.08, 0.91, 0.85 
428 0.59 0.97, 1. OJ' 0.87, 0.87 
429 0.59 1.16, 1.02, 1.04, 0.93 
Vhs 1 452 0.69 1.01, 1.16, 1.01, 0.92 
461 o.so 0.85, 0.93, 1.04, 0.95 
cs o.so 0.93, 1.11, 1.05, 0.86 
C25 0.62 1.07, 1. 07, o.8~, 1.01 
WT control 0.39, 0.46, 0.49, 0.46 
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f ected cells than in cells infected with wild type virus 
(Figure 3). In wild type infected cells, synthesis of ICPs 4 
and 0 could barely be detected at three h post-reversal of 
the cycloheximide block ( lane 2) , while the synthesis of 
these polypeptides was undetectable by seven h post-reversal 
(lane 4). Synthesis of ICP 27 was greatly reduced by seven h 
post-reversal. This all occurs against a background of 
cellular polypeptide synthesis which was also greatly reduced 
by seven h post-reversal (lane 4). In contrast, the three a 
polypeptides marked in Figure 3 continued being synthesized 
in abundant quantities at seven h post-reversal in cells 
infected with the mutant vhs 1 (lane 8). All six recombi-
nants were clearly wild type for a shutoff, that is, the 
synthesis of ICP 4, o, and 27 were all significantly reduced 
by seven h post-reversal (Figure 4), just as in the wild type 
control. The background synthesis of host polypeptides was 
also greatly reduced in these recombinants by seven h post-
reversal. These results indicate that the mutation(s) 
affecting the host and a shutoff activities of vhs 1 map 
between 0.49 and 0.63 map units in the viral genome. Since 
all six recombinants demonstrated wild type levels of both 
host and a shutoff, this is a strong indication that both 
events are controlled by the same or closely linked genes. 
These data, taken together, strongly suggests that the vhs 
function is intimately involved in the shutoff of both host 
and viral polypeptide synthesis, either alone or in conjunc-
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Figure 3. Synthesis of a Polypeptides by Wild Type and Yb§ 1 
virus. Cells were infected with 50 pfu per cell of wild type 
virus (lanes 1 through 4) or vhs 1 (lanes 5 through 8), all 
in the presence of 50 µg cycloheximide per ml. At 5 h post-
infection, the cycloheximide-containing medium was removed 
and replaced with medium containing 5 µg dactinomycin per ml. 
The cells were pulse labeled for 1 h intervals beginning at 
0.5 h (lanes 1 and 5), 3 h (lanes 2 and 6), 5 h (lanes 3 and 
7) or 7 h (lanes 4 and 8) after removal of the cycloheximide. 
The labeled polypeptides were analyzed by electrophoresis on 
9.25% polyacrylamide gels as previously described (160). The 
a polypep~ides ICP 4, o, and 27 are labeled to the left of 
lane 1 and are marked by dots to the left of lane 5. 
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Wild Type Vhs 1 
0.5h 3h 5h 7h 0.5h 3h 5h 7h 
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Figure 4. The Synthesis of a Polypeptides by Recombinant 
virus. Cells were mock infected (lane 1) or infected with 50 
pfu per cell of the indicated recombinant virus, all in the 
presence of 50 µg cycloheximide per ml. The cycloheximide~ 
containing medium was removed at 5 h post-infection and 
replaced with medium containing 5 µg dactinomycin per ml. 
The cells were pulse labeled for 1 h intervals beginning at 
0.5 h (lanes 1, 2, 4, 6, a, and 10), or 7 h (lanes 3, 5, 7, 
9, 11, and 13) after removal of the cycloheximide. Labeled 
polypeptides were analyzed as described for Figure 3. The a 
polypeptides ICP 4, o, and 27 are labeled to the left of lane 
2 and are marked by dots to the left of lanes 4, 6, a, 10, 
and 12. 
Mock Rec 60 Rec 86 Rec 93 
0.5h 0.5h 7h 0 .Sh 7h 0.Sh 7h 
",. 
1 2 3 4 5 6 7 
Rec 108 Rec 215 
0 .5h 7h 0.Sh 7h 
-
8 9 10 11 
Rec 291 
0.5h 7h 
12 13 
-.J 
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tion with other viral and/or cellular functions. Subsequent 
data from another laboratory demonstrated that both the host 
shutoff and a shutoff phenotype of vhs 1 could be rescued by 
a 256 bp fragment, and that this fragment mapped to a single 
open reading frame, named UL 41. This is in complete agree-
ment with the data presented here. 
Proteins Associated with mRNA in Infected Cells 
one possible function for the protein component of mRNP 
is that of regulating mRNA stability (48). It is therefore 
possible that one effect of the vhs function is to alter the 
proteins associated with mRNA in infected cells, to thereby 
increase the susceptibility of the mRNA to endogenous ribo-
nucleases. To test this hypothesis, cells were mock infected 
or infected with wild type or vhs 1 virus and the intact 
cells were exposed to ultraviolet (UV) light (1). This 
method covalently crosslinks only those proteins intimately 
associated with mRNA (197). After cells were lysed with 
detergent, the cytoplasmic material was passed over an oligo-
(dT)-column (5), and messenger ribonucleoprotein particles 
were recovered. Metabolic labeling of the proteins using 
[ 35S J methionine allowed the protein components of mRNPs to be 
visualized by digesting the mRNA with nucleases and separat-
ing the proteins by SDS-polyacrylamide gel electrophoresis 
followed by fluorography (1). 
The first order of business was to demonstrate that the 
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UV crosslinking procedure would yield results in agreement 
with other researchers' work. HeLa cells were labeled with 
[ 35S]methionine for four h, then mock infected for three h in 
the absence of label. The cells were then UV-irradiated and 
mRNPs were prepared as described in Chapter 2. At least 
seven protein bands could be resolved in mRNPs from mock in-
fected cells (Figure SA, lane 1). Prominent bands were seen 
at 125, 73, and 52 kda, with minor bands at 49, 39, 34, and 
32 kda. The 73 kda protein has been shown to be the cyto-
plasmic poly(A) binding protein (1, 21). 
The isolation of these proteins as part of poly (A)+ 
mRNPs was dependent upon irradiation of the cells prior to 
lysis (compare Figure SB, lanes 1 and 2). This indicates 
that the proteins were intimately associated with mRNA within 
the intact cell and that the association was not due to 
artifactual interactions with the mRNA during cell fraction-
ation. 
The proteins associated with mRNA in cells infected with 
wild type HSV-1 was then examined. The protein profiles of 
mRNPs from mock and wild type virus infected cells were very 
similar (Figure SA, lanes 1 and 2). All of the major compo-
nents of mRNPs from mock infected cells were also components 
of mRNPs from wild type infected cells. Nevertheless, sever-
al quantitative changes were consistently seen in mRNPs from 
cells infected with wild type virus. The major host polypep-
tide of 52 kda was decreased in abundance, while the minor 
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Figures. Messenger RNPs from Wild Type and Mock Infected 
cells. A. HeLa cells were prelabeled for 4 h with [35s ]-
methionine and then mock infected (lane 1) or infected with 
20 pfu per cell of wild type HSV-1 (lane 2). The cells were 
incubated in the absence of label from o to 3 h post-infec-
tion, at which time mRNPs were prepared and analyzed. The 
molecular weights (in kilodaltons) of prominent proteins are 
shown to the left of lane 1. The 52 kda polypeptide whose 
abundance is decreased by wild type virus infection is marked 
by an open circle to the right of lane 1, while the 49 kda 
protein that is increased in abundance is labeled by a closed 
circle. B. Parallel cultures were labeled as in part A and 
infected with 20 pfu per cell of wild type HSV-1. At 3 h 
post-infection the cells were either irradiated with UV light 
( lane 1) or not irradiated ( lane 2) • The cells were then 
lysed and mRNP samples prepared according to the remainder of 
the normal protocol described in the Materials and.Methods. 
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host band of 49 kda was increased, both relative to the 73 
kda PABP. There was no apparent decrease in the levels of 
PABP in cells infected with wild type HSV 1 as described by 
aartkoski in previously published results (10). 
To examine the possibility that de novo synthesized 
viral polypeptides or cellular proteins synthesized following 
infection might be mRNP components, HeLa cells were mock 
infected or infected with 20 pfu per cell of either wild type 
or vhs 1 and labeled with [35S]methionine from zero to three h 
post infection. A striking decrease in the amount of labeled 
protein recovered from wild type infected cell mRNP compared 
to mock or vhs 1 infected cells was observed (Figure 6A). 
This decrease reflects the shutoff of host protein synthesis 
caused by infection with wild type but not vhs 1 virus (160). 
To compensate for this difference so as to compare the 
protein composition of mRNPs from mock, wild type, and vhs 1 
infected cells, approximately equal intensity exposures of 
the three lanes from Figure 6A were juxtaposed (Figure 6B). 
Once again, similar protein profiles were observed for mRNPs 
from mock and wild type infected cells. The decrease in 
abundance of the 52 kda polypeptide and increase in the 49 
kda protein relative to the 73 kda PABP were observed for 
mRNP proteins from wild type infected cells, but were not as 
obvious in these gel exposures as in Figure 5A. In addition, 
a minor 47 kda host polypeptide was decreased in abundance 
while a new minor band of 46 kda was observed (Figure 6B, 
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Figure 6. Messenger RNPs Synthesized Following Wild Type, 
Vhs 1, or Mock Infection. A. HeLa cells were mock infected 
(lane 1) or infected with 20 pfu per cell of wild type virus 
(lane 2) or vhs 1 (lane 3). The cells were labeled with 
[ 35S]methionine from o to 3 h post-infection, and mRNPs were 
prepared and analyzed at 3 h. Material from approximately 3 
x 107 cells were loaded onto each lane of the gel. B. 
Multiple exposures were obtained for the gel shown in part A, 
and exposures resulting in similar intensities for the mock 
(lane 1), wild type (lane 2), and vhs 1 (lane 3} infections 
were juxtaposed. The molecular weights (in kilodaltons) of 
prominent proteins are shown to the left of lane 1 in both A 
and B. 
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Significantly, the profile of mRNP proteins from 
cells infected with vhs 1 was similar to the protein pattern 
of mock infected cells, and did not show the changes charac-
teristic of wild type virus infection (Figure 6B, lane 3). 
Furthermore, no de novo synthesized viral proteins were 
detected in mRNPs from either wild type or vhs 1 infected 
cells. 
To test the apparent correlation between changes in mRNP 
composition and vhs activity, experiments were performed to 
determine whether the changes induced by wild type virus 
still occurred following infection under conditions that 
prevent viral gene expression, a hallmark of vhs induced host 
shutoff. Cells were prelabeled with [35S]methionine for four 
h, then mock infected or infected with 50 pfu per cell of ei-
ther wild type or vhs 1 in the presence of 5 µg dactinomycin 
per ml. Wild type virus induced the same changes in the 
presence of dactinomycin (Figure 7, lane 2) as in a produc-
tive infection. Cells infected with vhs 1 in the presence of 
dactinomycin showed the same pattern of proteins as mock 
infected cells (Figure 7, lanes 1 and 3). 
Taken together, these experiments suggest that infection 
of HeLa cells with wild type virus leads to a change in the 
proteins associated with mRNA, as determined by UV cross-
linking. Since these changes were detected in the presence 
of dactinomycin, this implicates a component of the incoming 
virion. Likewise, the absence of any change in the protein 
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Figure 7. Changes in mRNP Structure occur in Wild Type 
Infections in the Absence of Viral Gene Expression. HeLa 
cells were prelabeled with [35S]methionine for 4 h and then 
mock infected (lane 1) or infected with 50 pfu per cell of 
wild type virus (lane 2) or vhs 1 (lane 3), all in the pres-
ence of 5 µg dactinomycin per ml. Messenger RNPs were pre-
pared at 3 h post-infection. The molecular weights (in 
kilodaltons) of prominent proteins are shown to the left of 
lane 1. 
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profile of mRNPs isolated from cells infected with vhs 1, a 
mutant defective in the virion-associated host shutoff of 
translation, further implicates the vhs function as perhaps 
involved in the alteration of mRNP proteins (103). No repro-
ducible changes in the amount of poly(A) binding protein were 
ever detected, a result in conflict with previously published 
data (10). 
An In Vitro Degradation System to Study the Vhs Function 
The HSV virion host shutoff (vhs) protein is known to 
induce rapid degradation of host and viral mRNAs in the 
cytoplasm (107,143,144,160, 184,206). In an effort to devel-
op an in vitro mRNA degradation system to study the vhs 
function, the rates of mRNA degradation in in vitro transla-
tion extracts prepared from mock infected HeLa cells, from 
wild type HSV-1 infected HeLa cells, and HeLa cells infected 
with the mutant vhs 1, which encodes a defective vhs polypep-
tide (160), were compared. HeLa cells were chosen because 
they are readily infected with HSV and because numerous 
studies have proven them to be a particularly suitable cell 
line for the preparation of in vitro translation extracts. 
Al though in vivo studies indicate that vhs induced mRNA 
degradation does not require efficient ongoing translation of 
the mRNA (184,206), in vitro translation extracts were pre-
pared initially because it was reasoned that these would be 
the best initial approximation of a functional cytoplasm. 
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Extracts were prepared using a procedure shown by Brown 
and coworkers to be suitable for the preparation of highly 
active in vitro translation extracts from a variety of cul-
tured cells (27). This procedure involves brief exposure of 
the cell monolayers to lysolecithin in order to permeabilize 
the cells, followed by harvesting the cells directly into 
buffer containing the components required for in vitro trans-
lation, disruption of the cells by repeated passage through a 
25-gauge needle, and removal of the nuclei by low speed 
centrifugation. This protocol was chosen because it is 
simple and rapid, making it possible to prepare and analyze 
the activity of extracts on the same day. This allowed all 
the experiments to be performed using freshly prepared ex-
tracts, and eliminated the need to freeze any part of the 
cell-free system, an obvious advantage in view of the possi-
ble detrimental effects that freezing and thawing might have 
upon the activities of as yet uncharacterized factors. 
To optimize the concentration of lysolecithin needed to 
permeabilize HeLa cells and to verify that this procedure 
yielded active in vitro translation extracts, standard reac-
tion mixtures were prepared using a variety of lysolecithin 
concentrations in the permeabilization buffer. Unlabeled me-
thionine was omitted from the reaction buffer and [35S]methi-
onine was added to a concentration of 75 µCi per ml. At 
various times after the start of incubation at 30°C, aliquots 
were withdrawn, and the amount of radioactivity incorporated 
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into TCA-precipitable material was determined as previously 
described (160}. Exposure of the HeLa cells to JOO µg lyso-
lecithin per ml was found to be optimal for in vitro transla-
tion. As can be seen in Figure 8, for extracts prepared with 
this concentration of lysolecithin, efficient in vitro trans-
lation continued for approximately 40 min, after which the 
amount of incorporated label leveled to a plateau. 
In Vitro Degradation .Qf Host mRNAs 
At this point, experiments were begun to study the in 
vitro degradation of host mRNAs. The vhs function was origi-
nally identified on the basis of its ability to induce rapid 
degradation of host mRNAs and the concomitant shutoff of host 
polypeptide synthesis (see above}. To determine whether HeLa 
cell lysates would be suitable for in vitro studies of the 
vhs function, standard translation extracts were prepared 
from mock infected cells and from cells five h after infec-
tion with 20 pfu per cell of either wild type HSV-1 or the 
mutant vhs 1. The extracts were incubated at 30°C, aliquots 
were withdrawn at various times, extracted with phenol and 
chloroform, and the decay of specific cellular mRNAs analyzed 
by Northern blotting. To control for the total amount of RNA 
loaded onto each lane of the gel, the blots were also probed 
for 28S ribosomal RNA, and the amount of mRNA was normalized 
to the amount of 28S rRNA prior to plotting the mRNA decay 
curve. 
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Figure 8. In Vitro Translation by HeLa Cell Extracts and 
Determination of Appropriate Lysolecithin Concentration. In 
vitro mRNA degradation extracts were prepared from mock in-
fected HeLa cells using three different concentrations of 
lysolecithin. Each extract was then examined for its effi-
ciency of translation. Each extract was prepared in standard 
reaction buffer containing 2.5 mM Mg(OAc) 2 , lacking unlabeled 
methionine, and supplemented with [35S]methionine to 75 µCi 
per ml. The reaction mixture was incubated at J0°C. At 
various times samples were withdrawn, and the amount of 
radioactivity incorporated into trichloroacetic acid-pre-
cipitable material was determined as described previously 
(160). 
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In these initial experiments the decay of endogenous 
cellular mRNAs was studied, instead of the decay of exoge-
nously added mRNAs. This was because the structure of mes-
senger ribonucleoprotein particles (mRNPs) reconstituted on 
exogenous mRNAs might differ from that of endogenous mRNPs. 
This mRNP structure could easily affect mRNA stability, and, 
as shown above, HSV infection has been shown to induce 
changes in mRNP structure that correlate with a wild type 
virion host shutoff function (103). Focussing upon the decay 
of endogenous mRNAs should, therefore, remove one potential 
variable from the experiments. In addition, the results 
involving the decay of endogenous mRNAs should provide a base 
line for later attempts to study the degradation of exogenous 
message. 
The in vitro decay of the cellular mRNA encoding glycer-
aldehyde-3-phosphate dehydrogenase (GAPD) is shown in Figures 
9 and 10. GAPD mRNA was chosen for study because it has a 
long in vivo half-life in uninfected cells (213), but is 
sensitive to vhs induced degradation upon infection with wild 
type HSV-1 (184). Thus, any vhs induced reduction in message 
stability should be more easily detected for this mRNA than 
for a message that is inherently unstable. GAPD mRNA was 
relatively stable for at least four h in extracts prepared 
from mock infected cells (Figure 9, lanes 1-5; Figure 10). 
In contrast, this message decayed rapidly in extracts from 
cells infected with wild type HSV-1, so that little detect-
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Figure 9. In Vitro Degradation of Host mRNAs. Standard in 
vitro mRNA degradation extracts were prepared from HeLa cells 
5 h after mock infection (lanes 1 through 5), or infection 
with 20 pfu of wild type HSV-1 (lanes 6 through 9) or vhs 1 
(lanes 10 through 14) per cell. Samples were withdrawn from 
the reactions at oh (lanes 1, 6, and 10), 1 h (lanes 2, 7, 
and 11), 2 h (lanes 3 and 13), 3 h (lanes 4, 8, and 13), or 4 
h (lanes 5, 9, and 14). The samples were extracted twice 
with phenol-chloroform and twice with chloroform, and the 
RNAs were precipitated from ethanol. Samples of total cyto-
plasmic RNA were denatured with glyoxal, electrophoresed 
through 1% agarose gels, and transferred to Nytran membranes 
by capillary blotting as described in the Materials and Meth-
ods. The membranes were then probed to detect GAPD mRNA and 
28S rRNA as described in the Materials and Methods. 
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Figure 10. Quantitation of In Vitro Decay of Host mRNAs. 
The autoradiogram shown in Figure 9 was scanned, and the 
amount of GAPD mRNA in each lane was normalized to the amount 
of 28S rRNA. In panel A, the relative amounts of GAPD mRNA 
in mock infected, wild type virus infected, and vhs 1 infect-
ed cell extracts are plotted in arbitrary units. In panel B 
the amount of GAPD mRNA present in a sample from any of the 
three types of extracts is expressed as a fraction of the 
amount present at Oh in that kind of extract. 
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able message remained by one h after the start of incubation 
(Figure 9, lanes 6-9; Figure 10). That considerable vhs in-
duced degradation had occurred in vivo in wild type cells 
prior to the preparation of extracts is indicated by the fact 
that the intensity of the band formed by GAPD mRNA at zero h 
of incubation for wild type extracts was reduced considerably 
relative to that observed at zero h for mock of vhs 1 in-
fections (compare Figure 9, lanes 1, 6, and 10 with Figure 
10). In contrast to the case for wild type infected cell ex-
tracts, in extracts prepared from cells infected with vhs 1, 
GAPD mRNA was as stable as in extracts from mock infected 
cells (Figure 9, lanes 10-14; Figure 10). In vitro decay was 
specific for mRNA, as evidenced by the fact that 28S rRNA was 
equally stable in mock, wild type, and vhs 1 infected cell 
extracts. All told, the rank order of in vitro decay rates 
of GAPD mRNA was the same as that observed in mock, wild 
type, and vhs 1 infections in vivo. 
The vhs protein is a structural component of virions, 
and is, therefore, able to induce degradation of host mRNAs 
in the absence of prior de novo viral gene expression (see 
above). Thus, virion host shutoff is induced by UV-inacti-
vated virus, as well as following infection of cells in the 
presence of dactinomycin to block viral transcription. To 
determine whether the accelerated degradation of GAPD mRNA 
observed in extracts from cells infected with wild type virus 
was induced by a virion component or required de novo viral 
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gene expression, in vitro degradation extracts were prepared 
from cells five h after a productive wild type virus infec-
tion, or five h after infection with 50 pfu per cell of wild 
type virus or yhs 1 in the presence of 5 µg dactinomycin per 
ml. As can be seen in Figure 11, degradation of the GAPD 
mRNA was equally rapid in extracts from cells infected with 
wild type virus in the presence or absence of dactinomycin. 
In contrast, GAPD mRNA was stable for at least five h of 
incubation in extracts from vhs 1 infected cells. Thus, the 
accelerated degradation of host mRNAs that was observed in 
extracts from cells infected with wild type HSV-1 was not 
dependent on de novo viral gene expression, and was, there-
fore, induced by a component of the infecting virions (104). 
In Vitro Degradation of Viral mRNAs 
Although vhs mutants were originally isolated on the 
basis of their defects in the degradation of cellular mRNAs 
and the shutoff of host protein synthesis, recent studies 
indicate that the vhs protein plays a central role in deter-
mining the half-lives of both viral and cellular mRNAs in the 
infected cell (107,143,144). Measurements of the half-lives 
of ten different viral mRNAs in cells infected with wild type 
virus or the mutant vhs 1 revealed several things. First, in 
wild type infections the half-lives of all ten messages, 
representing all kinetic classes of viral mRNAs, were very 
similar. second, the mutation in vhs 1 caused a dramatic 
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Figure 11. In Vitro Degradation in Extracts from Cells 
Infected in the Presence of Dactinomycin. Standard in vitro 
degradation extracts were prepared from cells 5 h after 
infection with 50 pfu of wild type virus or vhs 1 per cell 
in the presence of 5 µg of dactinomycin per ml or 5 h after 
infection with 50 pfu of wild type virus per cell in the ab-
sence of any drugs. The extracts were incubated at 30°C for 
the indicated times, at which point samples were withdrawn 
and total RNAs were extracted and analyzed for GAPD mRNA and 
28S rRNA by Northern blotting as described in the legend to 
Figure 9. Autoradiograms were scanned with a Hoeffer model 
GSJ00 scanning densitometer, and the amount of GAPD mRNA was 
normalized to the amount of 28S rRNA. The amount of GAPD 
mRNA remaining at various times was plotted as a fraction of 
the amount present at oh. 
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increase in the stabilities of all ten messages (144). Thus, 
the vhs protein induces the largely nonselective degradation 
of both viral and cellular mRNAs in vivo. 
To determine whether degradation of viral mRNA was also 
accelerated in the .in vitro message degradation system, in 
vitro degradation extracts were prepared from cells five h 
after infection with wild type virus or vhs 1, and analyzed 
for the degradation of the mRNA encoding the viral thymidine 
kinase (TK). As can be seen in Figures 12 and 13, TK mRNA 
was degraded rapidly in in vitro extracts from cells infected 
with wild type HSV-1, but was relatively stable for at least 
four h in extracts from cells infected with vhs 1. There-
fore, once again the in vitro results paralleled those ob-
served in vivo. 
Characterization of the In Vitro mRNA Degradation System 
In all respects examined to this point, in vitro deg-
radation of host and viral mRNAs observed in HeLa cell ex-
tracts were comparable to vhs induced mRNA degradation ob-
served in vivo. This system, therefore, was presumed to be 
an adequate in vitro model system to study vhs mediated mRNA 
degradation. The next set of experiments were designed to 
characterize some of the biochemical requirements of the in 
vitro mRNA degradation system. 
A preliminary experiment was undertaken to determine the 
effect of the placental ribonuclease inhibitor RNasin upon 
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Figure 12. In Vitro Degradation of Viral mRNAs. Standard in 
vitro mRNA degradation extracts containing 5 mM Mg2+ were 
prepared from cells 5 h after infection with 20 pfu of wild 
type HSV-1 (lanes 1 through 6) or vhs 1 (lanes 7 through 13) 
per cell. The extracts were incubated at 30°C for the indi-
cated times, at which point samples were withdrawn and total 
RNAs were prepared at Oh (lanes 1 and 7), 15 min (lanes 2 
and 8), 30 min (lanes 3 and 9), 1 h (lanes 4 and 10), 2 h 
(lanes 5 and 11), 3 h (lanes 6 and 12), and 4 h (lane 13) 
after the start of incubation. The amount of viral thymidine 
kinase (TK) mRNA was then analyzed by Northern blotting as 
described in Figure 9. 
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Figure 13. Quantitation of In Vitro Degradation of Viral 
mRNAs. Standard in vitro mRNA degradation extracts contain-
ing 20 mM Mg2+ were prepared from cells 5 h after infection 
with 20 pfu of wild type HSV-1 or vhs 1 per cell. The ex-
tracts were incubated at J0°C for the indicated times, at 
which point samples were withdrawn and total RNAs were ex-
tracted and analyzed for TK mRNA and 28S rRNA by Northern 
blotting as described in Figure 9. Autoradiograms were 
scanned with a Hoeffer model GSJOO scanning densitometer, and 
the amount of TK mRNA remaining at various times was plotted 
as a fraction of the amount present at Oh. Error bars in-
dicate the standard errors of the means determined from 
replicate experiments. 
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vhs induced mRNA decay. Parallel degradation extracts were 
prepared from HeLa cells five h after infection with 20 pfu 
per cell of either wild type or vhs 1. RNasin was included 
at a concentration of 100 units per ml in half of the reac-
tion mixtures, while it was omitted from the other half. 
Regardless of its presence or absence, mRNAs were very stable 
in extracts derived from cells infected with vhs 1, while 
they decayed rapidly in extracts from cells infected with 
wild type virus (data not shown). Because the addition of 
RNasin did not inhibit vhs induced degradation and its inclu-
sion might inhibit spurious nucleases, RNasin was included as 
a component in the standard in vitro reaction buffer and was 
present in all of the other experiments described in this 
section. 
The next set of experiments was undertaken to ascertain 
whether the in vitro vhs activity could be inactivated by 
pretreating the extracts with heat or proteinase K. Three 
parallel in vitro degradation extracts were prepared from 
HeLa cells five h after infection with 20 pfu per cell of 
wild type HSV-1. One extract was heated to 90°C for 10 min, 
then chilled on ice. A second extract was supplemented with 
proteinase Kand digested at 30°C for 30 min, while the third 
extract was left untreated. All three extracts were then 
analyzed for in vitro vhs activity. As can be seen in Figure 
14, pretreatment of the extracts by either heating or pro-
teinase K digestion completely abolished vhs mediated in 
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Figure 14. Effect of Heat and Proteinase K Pretreatment upon 
Vhs-induced In Vitro Degradation. Standard in vitro mRNA 
degradation extracts were prepared from cells 5 h after 
infection with 20 pfu of wild type HSV-1 per cell. Extracts 
were pretreated either by the addition of proteinase Kand 
digestion for 30 min or by heating to 90°C for 10 min, after 
which the extracts were returned to 4°C. Control un-
pretreated extracts were left at 4°C until the start of 
incubation. The extracts were incubated at 30°C for the 
indicated times. Samples were withdrawn and total RNAs were 
extracted and analyzed for GAPD mRNA and 28S rRNA by Northern 
blotting, and the amount of GAPD mRNA in each sample was nor-
malized to the amount of 28S rRNA. 
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vitro degradation. These results are consistent with the in-
volvement of one or more heat-labile proteins in vhs mediated 
message turnover. 
Recently Brewer and Ross have shown that a factor that 
is present in the post-polysomal supernatant fraction from 
the cytoplasm of K652 cells, and which specifically acceler-
ates the decay of c-myc and c-myb mRNAs, is inactivated by 
brief digestion with micrococcal nuclease (25). To determine 
whether similar micrococcal nuclease pretreatment of extracts 
from HSV-1 infected cells would inactivate the in vitro vhs 
activity, standard in vitro degradation extracts were pre-
pared from HeLa cells five h after mock infection or infec-
tion with 20 pfu per cell of wild type HSV-1. The extracts 
were supplemented with micrococcal nuclease and CaC121 and 
then preincubated at 30°C for 10 min. EGTA was then added to 
chelate the ca2+ and thereby inactivate the micrococcal nu-
clease, and the extracts were chilled briefly on ice. Micro-
coccal nuclease is routinely used to deplete in vitro trans-
lation extracts of endogenous mRNAs and to render translation 
dependent upon exogenously addea message (147). Therefore, 
in order to provide, target RNA for the vhs induced degra-
dation activity after endogenous targets were depleted by 
micrococcal nuclease pretreatment, the extracts were supple-
mented with deproteinized total cytoplasmic RNA from an 
equivalent number of uninfected HeLa cells. The extracts 
were then incubated at 30°C and analyzed for in vitro decay 
r 
of exogenous GAPD mRNA as described above. 
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The results of 
this experiment are shown in Figure 15, indicating that 
micrococcal nuclease had no effect on the vhs activity induc-
ing mRNA degradation in vitro. 
Three conclusions can by drawn form the results of this 
experiment. First, pretreatment of the extract form wild 
type virus infected cells with micrococcal nuclease did not 
inhibit the rapid degradation of exogenous GAPD mRNA. That 
this degradation was due to the vhs activity and was not the 
results of residual micrococcal nuclease activity is in-
dicated by the fact that GAPD mRNA was relatively stable in 
the micrococcal nuclease-treated extracts from mock infected 
cells. Second, the fact that exogenous GAPD mRNA was 
degraded in the wild type infected cell extracts suggests 
that the in vitro mRNA degradation system will be useful for 
studying the decay of both exogenous and endogenous mRNAs. 
Third, 28S rRNA was stable in extracts from both mock 
infected and wild type infected cells. Since initially the 
total amount of 28S rRNA was a 50:50 mixture of endogenous 
and deproteinized exogenous 28S rRNA, the results indicated 
that in wild type infected cell extracts deproteinized 
exogenous GAPD mRNA was degraded much more rapidly than 
deproteinized exogenous 28S rRNA. This result is an 
additional indication that the RNase activity seen in wild 
type infected cell extracts was specific for mRNAs and was 
not the result of a nonspecific RNase. 
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Figure 15. Decay of Exogenous GAPD mRNA and 28S rRNA in 
Micrococcal Nuclease-treated In Vitro Degradation Extracts. 
standard in vitro mRNA degradation extracts were prepared 
from cells 5 h after infection with 20 pfu of wild type HSV-1 
per cell. The extracts were pretreated as described in the 
Materials and Methods with micrococcal nuclease in the pres-
ence of added ca2+, and deproteinized total cytoplasmic RNA 
from an equivalent number of cells was added to each extract. 
The extracts were incubated at 30°C for the indicated times. 
Samples were withdrawn and total RNAs were extracted and 
analyzed for GAPD mRNA and 28S rRNA by Northern blotting. 
The relative amount of 28S rRNA in mock infected and wild 
type infected cell extracts is plotted as a fraction of the 
amount present at oh. In contrast to other figures in this 
report, the relative amount of GAPD mRNA detected in mock 
infected and wild type infected cell extracts is plotted 
without being normalized to the amount of 28S rRNA present in 
the sample. 
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The next set of experiments was undertaken to examine 
the Mg2+ dependence of the in vitro degradation system. 
parallel in vitro degradation extracts were prepared from 
HeLa cells five h after infection with 20 pfu per cell of 
wild type HSV-1. Individual reaction mixtures were supple-
mented with concentrated Mg(OAc)i to bring the Mg2+ concentra-
tion to the desired level. The extracts were incubated for 
five hand analyzed for the decay of the viral TK mRNA. As 
shown in Figure 16, in vitro degradation of TK mRNA showed a 
strong dependence upon the concentration of Mg2+ ion. While 
a significant difference could be seen between the rates of 
degradation in wild type and vhs 1 infected cell extracts at 
a concentration of 5 mM Mg2+ (see Figures 12 and 13), increa-
sing the Mg2+ concentration to 20 mM or higher significantly 
increased the degradation rate in wild type extracts (Figure 
16). That the effect of raising the Mg2+ concentration was 
not simply the resuit of inducing nonspecific changes in mRNP 
structure or the activation of nonspecific nucleases is 
indicated by the fact that a significant difference in the 
mRNA decay rates in wild type and vhs 1 infected cell ex-
tracts was still observed at a Mg2+ concentration of 2 o mM 
(see Figure 18). This concentration of 20 mM Mg2+ was chosen 
as optimal for all experiments except that in Figure 11. 
A similar experiment was undertaken to determine the 
effect of varying the K+ concentration upon the rate of vhs 
mediated decay of TK mRNA (Figure 17). Parallel in vitro 
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Figure 16. Mg2+ Dependence of Vhs-induced mRNA Degradation. 
In vitro mRNA degradation extracts were prepared from cells 5 
h after infection with 20 pfu of wild type HSV-1 per cell. 
The extracts were prepared in standard reaction buffer modi-
fied to contain 2.5 mM, 10 mM, 20 mM, or 40 mM Mg(OAc) 2 • The 
extracts were incubated at J0°C for the indicated times. 
Samples were withdrawn and total RNAs were extracted and ana-
lyzed for TK mRNA and 28S rRNA by Northern blotting, and the 
amount of TK mRNA in each sample was normalized to the amount 
of 28S rRNA. 
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degradation reaction were prepared from HeLa cells five h 
after infection with 20 pfu per cell of wild type HSV-1. In 
these reaction, the Mg2+ concentration was held at a constant 
20 mM, while the K+ ion concentration was varied from seven 
to 500 mM. As can be noted in Figure 17, efficient degrada-
tion of TK mRNA was observed at K+ concentrations from seven 
to 200 mM, while increasing the K+ concentration to 500 mM 
severely inhibited the degradation reaction. AK+ concentra-
tion of seven mM was used in all the other experiments repor-
ted in this section. 
The vhs mediated in vitro mRNA degradation system was 
next tested for its dependence upon the components of an 
energy generating system, namely ATP, GTP, creatine phos-
phate, and creatine phosphokinase. Parallel in vitro degra-
dation extracts were prepared from HeLa cells at five h after 
infection with 20 pfu per cell of either wild type HSV-1 or 
the mutant vhs 1. Half of the reactions contained all of the 
components of' the standard reaction, while the energy gener-
ating system components listed above were omitted from the 
other half. As shown in Figure 18, efficient vhs induced 
degradation of TK mRNA occurred in the presence (Figure 18A) 
and absence (Figure 18B) of the components of an energy gen-
erating system. 
The final series of experiments was performed to begin 
to fractionate the in vitro degradation extract, to determine 
where the vhs induced degradation function was localized. An 
114 
Figure 17. K+ Dependence of Vhs-induced mRNA Degradation. 
In vitro mRNA degradation extracts were prepared from cells 5 
h after infection with 20 pfu of wild type HSV-1 per cell. 
The extracts were prepared in standard reaction buffer modi-
fied to contain 7 mM, 100 mM, 200 mM, or 500 mM KCl. The 
extracts were incubated at 30°C for the indicated times. 
Samples were withdrawn and total RNAs were extracted and ana-
lyzed for TK mRNA and 28S rRNA by Northern blotting, and the 
amount of TK mRNA in each sample was normalized to the amount 
of 28S rRNA. 
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Figure 18. Dependence of Vhs-induced mRNA Degradation upon 
the components of an Energy-generating System. In vitro mRNA 
degradation extracts were prepared from cells 5 h after 
infection with 20 pfu of wild type HSV-1 or vhs 1 per cell. 
The extracts were prepared either in standard reaction buffer 
{A) or in standard reaction buff er from which ATP, GTP, 
creatine phosphate, and creatine phosphokinase had been omit-
ted {B). The extracts were incubated at 30°C for the indi-
cated times. Samples were withdrawn and total RNAs were ex-
tracted and analyzed for TK mRNA and 28S rRNA by Northern 
blotting, and the amount of TK mRNA in each sample was nor-
malized to the amount of 28S rRNA. 
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initial experiment was performed to see if crude solubilized 
virions had any inherent ribonuclease activity. Both wild 
type and vhs 1 virion extracts were prepared using 0.5% NP-
40, and were added to mock infected cell extracts. Figure 19 
shows the results of such an experiment. Wild type virion 
extracts were no more able to degrade endogenous GAPD mRNA 
than were vhs 1 extracts. Therefore, experiments turned away 
from fractionation of the virions and turned towards frac-
tionation of infected cell extracts. Extracts were prepared 
from mock infected cells, or from cells two h after infection 
with 20 pfu per ml of wild type or vhs 1. The extracts were 
layered onto small sucrose gradients and centrifuged to 
separate a polysomal precipitate from a soluble supernatant. 
Polysome pellets from all three infection types were re-
solubilized in the standard reaction buffer and incubated as 
before. These polysomal fractions were examined for their 
ability to degrade GAPD mRNA. As shown in Figure 20, no deg-
radation activity could be detected. Therefore, polysome 
pellets from all three infection types were mixed with solu-
ble supernatants from all three infection types, making nine 
possible combinations. All combination extracts were then 
examined for their ability to mediate in vitro degradation of 
the cellular GAPD mRNA. As can be seen in Figure 21, only 
those mixed extracts that contained a wild type soluble 
fraction were able to mediate the degradation of GAPD mRNA. 
It appears, then, that the wild type supernatant contains a 
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factor that mediates the in vitro degradation of GAPD mRNA, 
and to a first approximation, all polysome pellets were 
functionally equivalent. 
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Figure 19. Extent of mRNA Degradation in Mock Infected Cell 
Extracts Supplemented with Viral Extracts. standard .in vitro 
mRNA degradation extracts were prepared from HeLa cells 5 h 
after mock infection. Crude viral extracts were prepared 
from both wild type and vhs 1 virus, using 0.5% NP-40, in a 
procedure described by Preston et al. (158). The viral ex-
tracts were then added to the mock infected cell extracts, 
and the extracts were incubated at 30°C for the indicated 
times, at which point samples were withdrawn and total RNAs 
were extracted and analyzed for GAPD mRNA and 28S rRNA by 
Northern blotting. Mock extract controls were treated with 
the NP-40 buffer used to prepare the viral extracts. Auto-
radiograms were quantitated as described in the Materials and 
Methods, and the fraction of GAPD mRNA is plotted here. 
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Figure 20. Extent of TK mRNA Degradation in Isolated Poly-
somes Derived from Infected Cells. Polysomal fractions were 
prepared from HeLa cells 5 h after infection with wild type 
or vhs 1 virus, as described in the Materials and Methods. 
The polysomal pellets were resuspended in standard in vitro 
mRNA degradation buffer, and the extracts were incubated at 
30°C for the indicated times, at which point samples were 
withdrawn and total RNAs were extracted and analyzed for TK 
mRNA and 28S rRNA by Northern blotting. Autoradiograms were 
quantitated as described in the Materials and Methods, and 
the fraction of TK mRNA is plotted here. 
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Figure 21. Extent of GAPD mRNA Degradation in Polysome 
Pellets Supplemented with Soluble Supernatants. Polysome 
pellets were prepared from HeLa cells 5 h after mock infec-
tion, or 5 h after infection with 20 pfu per ml of wild type 
or vhs 1 virus, as described in the Materials and Methods. 
Soluble supernatants from each infection type were saved, and 
supplemented with concentrated stock solutions to obtain the 
appropriate standard in vitro degradation buffer. The solu-
ble supernatants were then added to the polysome pellets in 
all nine possible combinations, and the mixed extracts were 
incubated at 30°C for the indicated times, at which point 
samples were withdrawn and total RNAs were extracted and 
analyzed for TK mRNA and 28S rRNA by Northern blotting. 
Autoradiograms were quantitated as described in the Materials 
and Methods, and the fraction of TK mRNA is plotted here. 
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DISCUSSION 
The experiments described herein were designed to study the 
genetic, molecular, and biochemical nature of the virion host 
shutoff {vhs) function of herpes simplex virus type 1. This 
function is responsible for the apparently indiscriminate 
degradation of both cellular and viral mRNAs, by an as yet 
undefined mechanism. The results described in this report 
have mapped the vhs function to a large EcoRl restriction 
fragment, have shown that the vhs function can alter the 
structure of messenger ribonucleoprotein particles in vivo, 
and have led to the development of an in vitro degradation 
system to study the vhs function. These experiments have 
begun to unravel the mechanism of tpe vhs function, and 
suggest other experiments that can determine precisely what 
that mechanism is. 
Marker Rescue of the Vhs Gene 
The first set of experiments was designed to determine the 
genetic locus of the vhs function. The vhs mutants were 
generated by bromodeoxyuridine mutagenesis, which could lead 
to mutations in several genes, none of which are lethal. The 
vhs mutants were isolated by their inability to effect the 
shutoff of host cell protein synthesis. Further ana~ysis of 
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the mutants showed that the synthesis of viral a polypeptides 
was prolonged relative to wild type virus. Genetic mapping 
of the vhs function is one way to determine whether the same, 
or a closely mapping, locus is involved in the shutoff of 
cellular polypeptide synthesis as well as the shutoff of a 
polypeptide synthesis. Proof that one gene was responsible 
for the vhs phenotype would require cloning and sequencing 
the region identified by the marker rescue technique de-
scribed here. 
This technique depends on the fact that intact viral DNA 
is infectious and, by transfecting a permissive cell line, 
will eventually yield progeny virus. The intact viral DNA is 
derived from a virus carrying the mutation to be studied, and 
will upon transfection give rise to progeny with a mutant 
phenotype. By co-transfecting intact mutant virus DNA with 
cloned fragments derived from wild type viral DNA, a recombi-
nation event spanning the mutation in the intact viral genome 
may occur. This event would "rescue" the mutant marker and 
restore a wild type phenotype to the resulting progeny virus. 
This technique is most often used to rescue temperature-
sensitive (ts) mutations, since a shift to the non-permissive 
temperature would inhibit the growth of the mutant progeny 
and allow only those progeny whose ts marker had been rescued 
to grow. This makes selecting the recombinants very easy, 
and allows a much larger number of progeny to be screened. 
In the case of the vhs 1 mutant, there was no ts marker 
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to facilitate selection. Therefore, all progeny virus had to 
be screened for the presence of the wild type host shutoff 
phenotype. This screen involved assaying small stocks of 
progeny derived from co-transfections for the ability to 
shutoff cellular polypeptide synthesis. A hallmark of wild 
type host shutoff is that it can occur in the absence of any 
viral gene expression. Therefore, the screen involved grow-
ing progeny virus in the presence of dactinomycin and assay-
ing the amount of radioactivity incorporated into TCA-pre-
cipitable material as a measure of ongoing host translation. 
Progeny virus that maintained the vhs 1 phenotype would not 
be expected to reduce the amount of TCA-precipitable material 
to the level found in wild type infected cell controls. In 
contrast, progeny from the co-transfection whose mutant 
marker was rescued would be expected to reduce the amount of 
TCA-precipitable material to the same level as wild type 
controls. 
Figure 2 demonstrates that, as expected, the vast major-
ity of progeny derived from the co-transfection retained 
their mutant phenotype. The host shutoff activity is ex-
pressed as percent of mock infected control experiments. The 
average value of the amount of radioactivity incorporated 
into TCA-precipitable material from these controls was made 
100 percent. The amount of incorporated radioactivity in the 
progeny virus was then expressed relative to this 100 percent 
value. A cutoff value of 70 percent of the mock level was 
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chosen as representing mutant vhs activity. Progeny at or 
below that level were rescreened for their phenotype, to more 
precisely determine if the phenotype was wild type or mutant. 
Table 1 shows that six progeny derived from the co-
transfection experiment retained their wild type vhs pheno-
type upon rescreening, whereas rescreened progeny from the 
control transf ection retained their mutant phenotype, as 
expected. This is because the only way progeny from the con-
trol transfection with intact vhs 1 DNA could have a wild 
type vhs phenotype is by reversion of the mutation, an event 
as yet unobserved in laboratory stocks of these virus. 
Therefore, a background reversion frequency was not observed. 
The co-transfection experiment was expected to yield some 
progeny with a wild type vhs phenotype. The co-transfected 
wild type DNA fragment was some 21 kb in length, presumably 
providing a sufficiently large region for recombination 
events to take place. Still, the recombination event had to 
be such that it spanned the vhs mutation, an occurrence 
judged to be infrequent. Therefore, the observed recombina-
tion frequency of 1. 6 x 10·2 was thought to be reasonable. 
Thus assured that the recombination event in these six 
re screened progeny rescued the defective shutoff of host 
polypeptide synthesis in vhs 1, the next experiment showed 
that the recombination event also rescued the defective a 
shutoff phenotype in that mutant (Figures 3 and 4). In six 
out of six cases, rescue of the defective host shutoff phe-
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notype led to rescue of the defective a shutoff phenotype. 
This result suggests that the two phenotypes are controlled 
either by the same gene, or two tightly linked genes. By 
using smaller and smaller cloned fragments derived from the 
EcoRl fragment A of wild type HSV-1 in co-transfection ex-
periments, it was hoped that further data could be obtained 
that demonstrated that the two phenotypes were controlled by 
the same gene. 
In the course of those subsequent experiments, it was 
learned that another group had succeeded in mapping the vhs 1 
mutation to a 256 bp fragment derived from the EcoRl fragment 
A (108). This group also utilized the marker rescue tech-
nique described above, but dispensed with the laborious 
screening and rescreening of the progeny virus by exploiting 
the fact that wild type virus quickly outgrows vhs 1 in cell 
culture (160). Hence, the resulting progeny from a co-tran-
sfection were not plaque-purified, but rather were passaged 
twice in cell culture to enrich for those putative recombi-
nants with wild type vhs activity. As a control, wild type 
virus, present in an initial mix of 1:100 relative to the 
mutant vhs 1, was shown to expand sufficiently in two pas-
sages to give the resulting mixed virus population a wild 
type vhs phenotype. Fine mapping studies, done by generating 
a variety of smaller subclones of the EcoRl fragment A from 
wild type, eventually led to the conclusion that a 256 bp 
fragment could rescue the vhs 1 mutation. The progeny res-
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cued with this small fragment were therefore wild type for 
both cellular and viral mRNA destabilization, leading the au-
thors to conclude that the same viral function controls these 
events. subsequent sequencing data has shown that the 256 bp 
fragment lies within the open reading frame UL 41, allowing 
this open reading frame to be identified as the vhs gene 
( 126) . 
It is evident, then, that one viral gene, the vhs gene, 
mediates the shutoff of both cellular and viral polypeptide 
synthesis by regulating the indiscriminate degradation of 
both cellular and viral mRNA. Sequencing the remaining five 
vhs mutants can offer significant insight into the nature of 
the vhs function, especially since three of these mutants are 
temperature sensitive for host shutoff, and the nature of 
these mutations may be 
regions of the protein. 
instructive in locating important 
The sequence of the wild type vhs 
gene has not yet provided much information concerning the 
mechanism of vhs mediated mRNA degradation, as it does not 
appear to share any homology to known proteins. Still, the 
sequence has provided much useful information about restric-
tion enzyme sites to exploit in developing deletion mutants 
and type 1 x type 2 fusion proteins, which may be very help-
ful in understanding the vhs mechanism. Likewise, regions of 
interest in the protein can be targeted for analysis by site-
directed mutagenesis. Most intriguing would be the develop-
ment of a vhs gene under the control of an inducibie pro-
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moter, leading to experiments to prove that the vhs function 
is the only viral function required to cause the rapid degra-
dation of cellular message. Transfection experiments with 
the intact vhs gene under the control of its own promoter 
indicate that the vhs gene can act to degrade target mRNA 
encoded by a transf ected CAT plasmid ( Schmidt and Read, 
unpublished results). 
Studies on mRNPs in HSV-infected Cells 
Much additional work on the genetic aspects of the vhs 
function must still be done. The experiments in this report, 
however, next focused on understanding the vhs function at 
the molecular level. As has often been mentioned, the target 
of the yhs function is mRNA. In eukaryotic cells, mRNA 
exists complexed with a set of proteins, in a structure 
called messenger ribonucleoprotein particles (mRNP). One 
possible role for these proteins is the protection of the 
mRNA moiety. Since the vhs function apparently attacks this 
mRNA, in an undefined manner, it is possible that the protec-
tive mRNP proteins are altered in some way to make the mRNA 
more susceptible to that attack. 
The process by which the proteins in mRNPs were studied 
involved the ultraviolet light irradiation of intact cells. 
This procedure covalently crosslinks intimately associated 
proteins to the mRNA, thereby greatly reducing artifactual 
mRNA-protein interactions after cell lysis. Indeed, the 
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cytoplasmic material was heated to 90°C in the presence of 
sos to prevent those kinds of nonspecific interactions. 
Therefore, the proteins eventually resolved on polyacrylamide 
gels were considered to be genuinely associated with mRNA in 
vivo. By isolating these proteins from mock, wild type, or 
vhs 1 infected cells, it was possible to demonstrate what 
changes, if any, occurred in the protein composition of 
mRNPs. 
Figure SA demonstrates that the majority of the proteins 
associated with mRNPs from mock infected cells were also 
associated with mRNPs from cells infected with the wild type 
virus. This is not surprising, as most of these proteins are 
thought to be important in translation. However, mRNPs 
isolated from wild type infected cells showed a decrease in 
the amount of a 52 kda major mRNP protein, and an increase in 
the amount of a minor 49 kda protein. These changes did not 
occur when cells were infected with the mutant vhs 1 (Figure 
6). Likewise, these changes occurred in the absence of viral 
gene expression (Figure 7). These data taken together impli-
cate the wild type vhs function as somehow responsible for 
these changes (103). 
It is important to reiterate that the changes in the 
proteins associated with mRNA in cells infected with wild 
type infected cells can occur in the absence of any viral 
gene expression (Figure 7). That is, the population of mRNA 
examined under these conditions derives entirely from cellu-
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lar genes. The only viral gene products present are those 
associated with the incoming virion. Yet the structure of 
these cellular mRNPs matches the structure of mRNPs derived 
from cells productively infected with wild type virus, when 
the mRNA population is largely viral in origin. This points 
out a common mechanism of the vhs protein on both cellular 
and viral mRNPs, and strengthens the contention that the vhs 
function is nonspecific. 
At issue is whether these changes are caused by the 
vhs function, or are an effect of the vhs function mediating 
the degradation of these mRNAs. It could be argued that the 
altered profile of mRNPs from cells infected with wild type 
virus was simply a characteristic of mRNPs that were in the 
process of being degraded. While this possibility cannot be 
excluded, all of the mRNPs that were isolated were suffi-
ciently intact to have poly(A) tails. In uninfected cells, 
mRNA turnover involves progressive shortening of the poly(A) 
tail followed by rapid 3' to 5' degradation of the body of 
the message. If this is also the case for vhs induced mes-
sage decay, the mRNPs isolated in this report must be either 
undegraded or at a very early stage of degradation. 
A previous report by Bartkoski also demonstrated that 
the protein profile of mRNPs in cells infected with wild type 
HSV are altered (10). These experiments, described in the 
Introduction, showed a decrease in abundance of a 52 kda 
protein as well as in a 74 kda protein, thought to be the 
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poly(A) binding protein. An increase in a 47 kda protein was 
also noted. several caveats about this experiments were 
noted in the Introduction, but the changes in the protein 
profile are in general agreement with the work in this re-
port. The decrease in the 52 kda protein was observed in 
both cases, and an increase in a 4 7 kda protein in Bart-
koski' s report (10) presumably correlated with an increase of 
a 49 kda protein in this report. The major difference is in 
the presence or absence of the 74 kda poly(A) binding pro-
tein. One possibility is to suggest that both observations 
are correct. In both reports, only poly(A)+ mRNPs were se-
lected. In the case of UV crosslinked mRNPs, perhaps suf-
ficient poly(A) must remain on the 3' end for interactions 
with both oligo(dT) and the covalently bound poly(A) binding 
protein. In Bartkoski's system, proteins were not covalently 
bound (10). This may allow mRNAs with shorter poly(A) tails 
to interact with oligo(dT). In other words, the protocol 
used in this report may select mRNAs with longer poly(A) 
tails. These mRNPs may not be as far along in the degra-
dation pathway as those in Bartkoski's report, although in 
both cases the presence of a poly(A) tail was assumed. 
Indeed the pool of poly(A)+ mRNA may be quite small in 
wild type infected cells, as evidenced by the lower amounts 
of mRNP material recovered from these cells noted in this 
report (Figure 6A), and by previous reports showing that HSV 
infection led to a decrease in the ratio of poly (A) + to 
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poly(A)· mRNA in the cells (136,205). Presumably, as active 
degradation takes place fewer mRNA species exist that can 
bind to oligo(dT} columns. The mRNP material recovered 
appeared to be intact, and, for the most part, carried the 
same complement of proteins as mock infected cells. In other 
words, the recovered material did not represent small degra-
dation products. Therefore, the conclusions in this report 
concerning the proteins profiles of intact mRNPs appear to be 
valid. 
In Vitro mRNA Decay Mediated 12¥ the Vhs Function 
In any case, the elucidation of the exact mechanism of 
the vhs protein is perhaps best accomplished by examining a 
vhs mediated in vitro mRNA degradation system. The final set 
of experiments involves the development and preliminary 
biochemical characterization of just such a system. As with 
any in vitro system, the initial concern was that the in 
vitro system approximate events known to occur in vivo. In 
this case, the in vitro system was required to reproduce the 
levels of mRNA stability in mock, wild type, and vhs 1 in-
fected cells. 
The in vitro system shares several important parallels 
with in vivo observations on the vhs function. First, host 
messages were degraded rapidly in extracts prepared from 
cells infected with wild type HSV-1, but not in extracts from 
mock infected cells or cells infected with the mutant vhs 1. 
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second, the accelerated turnover of host mRNAs occurred in 
extracts from cells infected with wild type virus in the 
presence of dactinomycin, indicating that the degradation was 
induced by a component of the infecting virions and was not 
dependent upon de novo viral gene expression. Third, accel-
erated turnover of viral mRNAs was observed in extracts from 
cells productively infected with wild type HSV-1, but not in 
extracts from vhs 1 infected cells. In each of the above 
cases, the most important observation supporting the fidelity 
of the in vitro system was the striking difference between 
the mRNA decay rates in extracts from cells infected with 
wild type virus and in extracts from vhs 1 infected cells. 
This indicates that the accelerated in vitro degradation of 
mRNAs was dependent upon infection of the cells with virions 
containing a functional vhs polypeptide, and was not simply 
the consequence of a nonspecific ribonuclease liberated 
during cell fractionation or induced as a consequence of 
viral infection per se. Finally, although the wild type vhs 
function induced accelerated in vitro turnover of both viral 
and cellular mRNAs, endogenous 28S ribosomal RNA was equally 
stable in extracts from mock infected cells and in extracts 
from cells infected with either wild type virus or vhs 1. 
This lends further support to the conclusion that the de-
gradati ve activity seen in wild type infected cell extracts 
was specific for mRNAs and was not due to a contaminating 
nonspecific nuclease that should have been detected in all 
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three kinds of extract. 
Analysis of the crude in vitro system showed that one or 
more factor.s necessary for in vitro vhs activity was inacti-
vated by heating the extracts to 90°C or by brief proteinase 
K digestion. These data are consistent with the involvement 
of one or more heat labile proteins in vhs induced degrada-
tion. In contrast, pretreatment of wild type extracts with 
micrococcal nuclease did not inhibit the subsequent degrada-
tion of added exogenous mRNA, indicating that the factors 
required for in vitro~ activity are apparently insensitive 
to treatments known to inactivate a number of small RNAs and 
ribonucleoproteins (97) as well as a factor that accelerates 
in vitro decay of c-myc and c-myb mRNAs (25). Furthermore, 
the finding that exogenous mRNAs were rapidly degraded in 
extracts from cells infected with wild type virus, but were 
relatively stable in extracts from mock infected cells sug-
gests that the in vitro degradation system will be suitable 
for studying the vhs induced decay of exogenous as well as 
endogenous mRNAs. It is also worth noting that in these 
experiments the source of the exogenous mRNA was total depro-
teinized cytoplasmic RNA containing a mixture of mRNA and 
ribosomal RNA. Thus, the results shown in Figure 15 indicate 
that added deproteinized mRNA was degraded more rapidly in 
wild type extracts than added deproteinized ribosomal RNA. 
This adds further support to the conclusion that the in vitro 
vhs activity observed in wild type infected cells was speci-
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fie for mRNA, and did not simply result from a contaminating 
nonspecific ribonuclease. 
Preliminary biochemical characterization of the 1n vitro 
mRNA degradation system from HSV infected cells indicates 
that it is similar in a number of respects to in vitro mRNA 
degradation systems from uninfected cells described pre-
viously by Ross (reviewed in 173) and others (146, 208). In 
particular, the vhs induced mRNA degradation activity was not 
inhibited by the placental ribonuclease inhibitor RNasin, and 
was dependent upon added divalent cation. Efficient vhs 
induced degradation occurred at K+ ion concentrations of up 
to 200 mM, but was inhibited by 500 mM K+. Also, mRNA de-
gradative activity was not dependent upon the addition of 
ATP, GTP, creatine phosphate or creatine phosphokinase. In 
each of these respects, the vhs induced ribonuclease activity 
was similar to the exonuclease shown by Ross and coworkers to 
induce degradation of histone mRNAs in extracts from K562 
erythroleukemia cells (175). 
Al though both systems required added divalent cation, 
the in vitro vhs activity reported here and the exonuclease 
described by Ross (175) apparently differ somewhat in the 
nature of their dependence upon added Mg2+. While the exo-
nuclease that degrades histone mRNA exhibited a broad optimum 
ranging from 5 to 20 mM Mg2+, the vhs mediated activity in 
the extracts described here was more strongly dependent upon 
added Mg2+. Thus, while a striking difference was observed 
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between mRNA decay rates in extracts from wild type virus 
infected and vhs 1 infected cells at Mg2+ concentrations 
ranging from 2.5 to 20 mM (Figures 9-13, and 16), the rate of 
mRNA degradation in wild type extracts increased continuously 
as the Mg2+ concentration was raised to 20 or 40 mM. At 
present, the reason for this difference in the Mg2+ depen-
dence of the two in vitro systems is unclear. It is possible 
that one or more of the proteins involved in vhs induced 
degradation may have an increased Mg2+ dependence. Or, 
higher Mg2+ concentrations may favor a conformational change 
in mRNP structure that renders the mRNA more susceptible to 
vhs induced degradation. 
Besides providing the groundwork for future experiments, 
the preliminary biochemical characterization of the vhs 
induced ribonuclease activity allows it to be distinguished 
from several previously characterized RNases that are common-
ly found in cell extracts. Pancreatic ribonuclease is resis-
tant to boiling, but is inhibited by RNasin (146). The fact 
that the vhs mediated activity is sensitive to heating to 
90°C but is not inhibited by RNasin therefore indicates that 
it does not involve a pancreatic-type ribonuclease. A nuc-
leolar exonuclease activity has been described that, like the 
vhs induced ribonuclease activity, is dependent upon added 
Mg2+ ( 111) • However, unlike the vhs induced enzyme, the 
nucleolar ribonuclease is inactive at K+ ion concentrations 
above 90 mM. A lysosomal acid ribonuclease has been de-
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scribed (182). However, unlike the vhs induced enzyme, it 
does not require added Mg2+. 
In several previously characterized in vitro degradation 
systems, the ribonucleases responsible for mRNA turnover were 
found to be polysome associated. This was the case for the 
nucleases responsible for the in vitro degradation of histone 
and c-myc mRNAs, although in both cases the decay rate was 
greatly accelerated by soluble factors present in a post-
polysomal supernatant fraction of the cytoplasm (25,152). In 
addition, Brawerman and coworkers have recently reported a 
ribonuclease that is associated with polysomes as well as 
free messenger ribonucleoprotein particles in a variety of 
mammalian cells (9). 
The existence of a polysome associated ribonuclease was 
examined in the vhs mediated in vitro degradation system. 
The in vitro extracts from HSV infected HeLa cells were 
separated by centrifugation into a polysome pellet and a 
post-polysomal supernatant. Polysomal mRNAs from cells 
infected with wild type virus or vhs 1 were both found to be 
as stable as polysomal mRNA from mock infected cells when 
those polysomes were resuspended and incubated in the stan-
dard reaction buffer (Figure 20). However, readdition of the 
post-polysomal supernatant from wild type infected cells 
extracts to polysomes from any source restored the rapid 
degradation of the mRNAs (Figure 21). These data indicate 
that one or more factors required for vhs induced mRNA 
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degradation is found in the post-polysomal supernatant frac-
tion of wild type infected cell extracts. This suggests 
either that the post-polysomal supernatant alone is suffi-
cient for in vitro mRNA degradation, or that this supernatant 
contains a trans-acting factor that modulates a polysome as-
sociated nuclease. Experiments by other workers using in 
vitro degradation systems derived from uninfected cells sug-
gests that the degradation activity resides in the polysomal 
fraction, but that it is modulated by unknown components in 
the supernatant fraction. 
Dominance. Secondary Shutoff. and the Yh§. Function 
One issue as yet unaddressed is that of the dominance of 
the vhs 1 mutation. It was previously noted that in mixed 
infections where the ratio of vhs 1 to wild type virus was on 
the order of 100:1 (108), or even 1:1 (G. s. Read, unpub-
lished data), the dominant phenotype was that of vhs 1, that 
is, there was no detectable host shutoff. These observations 
led to the proposal that the active vhs function is composed 
of a mul timer of two or more vhs proteins. Coupling one 
mutant copy of the vhs protein from vhs 1 to a wild type copy 
abrogates vhs activity. This issue could be easily examined 
in the in vitro system, initially by mixing various amounts 
of vhs 1 and wild type infected cell extracts, and ultimately 
by mixing amounts of purified vhs protein from the two 
sources derived by use of antibody against the vhs protein 
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(see below), and examining the extent of in vitro degradation 
of a given message. The antibody would also be useful in 
glycerol gradients or gel exclusion chromatography followed 
by Western blotting of the fractions, to see if the native 
state of the protein is as a multimer of the approximately 58 
kda monomer vhs protein. 
A second unexamined issue is that of secondary shutoff, 
which remains a poorly understood phenomenon. Work done in 
the late 1970s suggested that a second stage of host shutoff 
existed, and that this secondary shutoff required viral pro-
tein synthesis (56,82,139,196). Secondary shutoff was re-
visited by Frenkel and Read in 1983 (160). Experiments with 
the vhs mutants showed that, although these viruses were de-
fective in virion associated host shutoff, they were capable 
of secondary shutoff if infection was allowed to proceed past 
the expression of a polypeptides. The conclusion was that 
these events were separable and controlled by separate viral 
functions. 
A simple hypothesis for secondary shutoff is that the 
host protein synthetic apparatus is overwhelmed by viral 
mRNA, and that this overabundance of viral mRNA does not 
exist until somewhat later in infection. Exclusion of cel-
lular mRNA from polysomes by this large quantity of viral 
mRNA would lead to shutoff of host polypeptide synthesis. 
This secondary shutoff is accompanied by degradation of host 
mRNA in both wild type and vhs 1 infected cells (206)-. This 
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may suggest that there is a viral function(s) that controls 
this event, as the authors hypothesize, or that an indiscri-
minate cellular RNase is activated at late times after infec-
tion. Degradation of host mRNAs at late times after infec-
tion with vhs 1 could easily be examined both in vivo and in 
vitro. An in vitro secondary shutoff system could be ana-
lyzed in the same way as the initial vhs mediated mRNA degra-
dation system examined in this report to determine the degree 
of similarity between these two shutoff events. Putative 
mutants in viral functions that control secondary shutoff 
could also be examined in such an in vitro system. 
It is difficult, however, to postulate the existence of 
a second viral function controlling mRNA degradation at late 
times in vhs 1 infected cells. None of the experiments 
described here demonstrated any accelerated mRNA degradation 
in vhs 1 infected cells at any time during infection. If 
secondary host shutoff is a virally controlled phenomenon, 
acceptable hypotheses about the nature of that shutoff must 
account for discrimination between host and viral mRNAs. 
Cells infected with vhs 1 contain a jumble of mRNAs, both 
cellular and viral, all competing for a limited translational 
capacity. The volume of messenger RNA late in infection in 
cells infected with vhs 1 must be overwhelming, as all of the 
positive control elements of HSV-1 function unchecked by the 
vhs protein, normally acting to actively degrade both cellu-
lar and viral messages. This may be what makes the simple 
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hypothesis first proposed above the most plausible hypothe-
sis, namely that secondary shutoff is the result of uncon-
trolled viral transcription leading to the cessation of 
cellular translation. Since productive infection by HSV 
invariably leads to cell death, perhaps the degradation of 
mRNAs during secondary shutoff is a consequence of cell 
destruction, mediated by one or more indiscriminate cellular 
RNase activities, rather than by the elaboration of a new 
viral degradation function late in infection. 
Vhs Mediated Degradation: Hypotheses and Experiments 
Genetic and sequencing data prove that host and a shut-
off are mediated by the same gene, the vhs gene. A variety 
of supplementary data indicate that the gene product, the vhs 
protein, is responsible for the overall destabilization of 
cellular mRNA and viral mRNA of all kinetic classes. This 
destabilization is accomplished by the active degradation of 
both cellular and viral mRNAs, detected both in vivo and in 
vitro. The alteration in the mRNP structure in cells in-
fected with wild type HSV-1, notably the loss of a 52 kda 
protein, may be a consequence of this active degradation, a 
hypothesis which can be tested by experiments proposed below. 
One way to begin to examine this issue is by determining 
the protein profile of mRNPs isolated from the in vitro 
degradation system described in the Results. It has previ-
ously been shown that the mRNPs derived from in vitro trans-
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lation extracts carry the same protein complement as mRNP 
complexes from intact cells. Therefore, by exposing the vhs 
mediated in vitro degradation system to UV light, thereby 
crosslinking proteins to mRNA, it would be very easy to 
compare in vivo and in vitro protein profiles. Cell-free 
extracts derived from wild type infected cells would be 
expected to contain mRNPs with decreased levels of the 52 kda 
protein as observed in vivo, while vhs 1 infected cell ex-
tracts would yield mRNP protein profiles identical to those 
from mock infected cell extracts, and identical to comparable 
mRNP complexes extracted in vivo. 
To demonstrate that this alteration is an effect of vhs 
mediated mRNA degradation would also involve the examination 
of the in vitro degradation system. In this case, the pro-
teins associated with a specific mRNA would be examined. The 
choice of the message is important, with the emphasis being 
on a message with a short half-life. Therefore, a message 
like the one encoding c-myc would be appropriate. If the 
amount of 52 kda protein were reduced in this short-lived 
message, that might suggest that part of the degradation 
pathway involves removal of that protein from the body of the 
mRNA. To test this hypothesis, the c-IDY£ mRNA would be 
transcribed in vitro, and would be uniformally labeled with 
[ 32P]ribonucleotides. This labeled mRNA would then be added 
to an uninfected cell-free mRNA degradation extract, and at 
appropriate times after incubation, aliquots would be removed 
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for UV crosslinking. The proteins would be covalently linked 
to one or more labeled nucleotides, allowing the proteins to 
be visualized after polyacrylamide gel electrophoresis. An 
appropriate control for such an experiment would be to repeat 
the analysis using globin mRNA, a message with a long half-
life. 
A more direct analysis of the role of the 52 kda protein 
would require the development of an antibody against the 
protein. A cell-free mRNA degradation system derived from 
uninfected cells could be depleted of the 52 kda protein 
using that antibody. If removal of the 52 kda protein from 
mRNPs leads to a generalized increase in message instability 
in vitro, this may explain why the removal of this protein by 
the wild type vhs function causes the same to occur in vivo. 
Mechanistically, the vhs function may affect the affinity of 
the 52 kda protein for the mRNA, thereby exposing the mRNA to 
endoribonuclease attack. Or, the vhs function may activate a 
normal cellular mRNA degradation pathway, part of which in-
volves a progressive 3' to 5' degradation of the mRNA, start-
ing with the poly{A) tail. 
This 3' to 5' degradation may then lead to loss of the 
52 kda protein. By synthesizing transcripts with varying 
poly{A) tail lengths in vitro, and adding them to the .in 
vitro mRNA degradation system, the influence of the length of 
the poly{A) tail on the binding of the 52 kda and other mRNP 
proteins can be examined by the UV crosslinking protocol. An 
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unresolved question is whether the poly(A) tail itself is 
affected by the presence of the wild type vhs function. 
This issue could be approached by examining the average 
poly(A) tail length of specific mRNAs derived from cells 
infected with wild type and vhs 1. The viral thymidine 
kinase transcript would be an ideal choice for such an anal-
ysis, as it exhibits a marked difference in half-life in 
cells infected with wild type or mutant virus (144). Exami-
nation of the average poly(A) tail length of a specific mes-
sage involves the use of a short single strand DNA probe that 
hybridizes to a known internal position of the transcript 
(400 to 500 nucleotides 5' of the poly(A) site; 127). The 
hybrid is treated with RNase H, which recognizes and cleaves 
DNA-RNA hybrids. The cleavage products are resolved by 
electrophoresis in agarose gels, and the fragments are then 
transferred to a membrane for Northern blotting with a 3'-
specific probe. Upon autoradiography, the range of poly(A) 
tails will appear as a smear. The change over time of the 
size of this smear gives an indication of the extent of 
poly(A) tail loss. Presumably, there would be little change 
in the poly(A) tails of TK mRNA isolated from vhs 1 infected 
cells, whereas TK mRNA from wild type infected cells would be 
expected to show a rapid loss of the poly(A) tails. This 
same analysis could be performed on mRNAs derived from the in 
vitro degradation system described here. 
The loss of the poly (A) tail in wild type infected 
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cells, and wild type infected cell extracts, may support the 
contention that mRNA degradation in cells infected with wild 
type HSV occurs from a 3' to 5' direction, as has been re-
ported in other systems (24). By using probes specific for 
the 3' and 5' ends, the directionality of degradation of a 
specific message like the viral thymidine kinase or the 
cellular GAPD could be studied. The extent of degradation at 
each end can be determined by using these probes in Sl nucle-
ase mapping studies. By comparing the rate of disappearance 
of signal at the 3' end with the rate of signal disappearance 
at the 5' end, the directionality of the degradation could be 
determined. If the signal detected by the 3' probe disap-
pears with time, while the signal detected by the 5' probe 
remains relatively constant, a 3' to 5' directionality is 
presumed. Indeed, the presence of a small 5' fragment that 
remains undegraded has been reported in two separate in vitro 
mRNA degradation systems (25,208). These same experiments 
can be performed both in the .in vitro system and in vivo, 
where unconflicting results would be expected. 
Notwithstanding the results on the directionality of the 
degradation, studies could also be performed on the in vitro 
degradation of .in vitro synthesized RNA targets. Vhs 
mediated degradation of mRNAs may require specific targets. 
These targets can be prepared by .in vitro transcription of 
cloned cDNAs, either of cellular or viral origin. And, 
because these transcripts can be uniformally labeled with 
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[ 32P]ribonucleotides in vitro, the need for Northern blots is 
eliminated. The degradation products, if any, can be visual-
ized by direct autoradiography of the RNA glyoxal gels. Such 
experiments could be performed on RNA targets with and with-
out poly(A) tails, to see if the rate of in vitro degradation 
were influenced by this structure. Likewise, the in vitro 
synthesized transcripts can be treated with an in vitro 
capping extract to add a 5' cap, again to ascertain if such a 
structure influenced the rate of in vitro degradation. For 
the sake of completeness, chimeric transcripts, consisting of 
noncoding regions derived from viral mRNAs and coding se-
quences from cellular genes, and vice versa, could be gen-
erated and tested in vitro to reaffirm the nonspecificity of 
vhs mediated mRNA degradation. 
The in vitro data presented in this report, taken 
together, suggest that some cellular mRNA turnover system, 
perhaps polysome associated, is activated or modified by the 
vhs protein, present free in the cytoplasm. The cellular 
location of the vhs protein could be determined using a bio-
chemical purification scheme based upon following the degra-
dation activities of various fractions, but this might be 
complicated by the requirement of factors from several 
cellular compartments for full activity. The best way to 
examine the vhs function alone would be to raise antibodies 
to purified virions, or to a fusion protein derived from the 
cloned vhs gene. Indeed, antibodies to a yhs fusion protein 
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have been developed and are currently being analyzed. These 
antibodies could be used in several ways in the in vitro 
degradation system. For instance, the antibody could be 
added directly to a wild type infected cell extract to pre-
cipitate the vhs protein. Conceivably, if the vhs function 
acts by activating a normal cellular mRNA turnover pathway, 
the vhs function may not be needed continuously. Removal of 
the vhs protein with antibody at various times after incu-
bation would show whether message degradation continued 
unimpaired. 
such an antibody could also be used to prepare a puri-
fied source of vhs protein, either from infected cells or 
from solubilized virions. The purified vhs protein could be 
used to determine if the protein has inherent ribonuclease 
activity, or if it requires factors present in cell-free 
extracts for its activity. Obviously, one attractive hypo-
thesis concerning the need for both soluble and polysome-
associated factors in the in vitro degradation system is that 
the soluble factor is the vhs protein. This can easily be 
tested with purified vhs protein, by preparing polysome 
pellets from mock infected cells and adding the purified vhs 
protein to the resolubilized polysomes. The data presented 
in this report suggests that the source of the polysome 
pellet is irrelevant; it is the existence of a soluble factor 
in wild type infected cells that is important in activating 
the degradation activity. 
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Indeed, the entire polysome pellet may not be required. 
If polysome associated factors are required, it may be pos-
sible to wash off these factors by addition of high salt 
buffers to the polysome pellets. The post-polysomal super-
natant from wild type infected cell extracts would be added 
to these salt washed polysomes to determine if the degra-
dation activity remains. If the degradation activity is 
abrogated, readdition of the polysome salt wash fraction may 
restore activity, demonstrating that both a polysomal and 
post-polysomal function are required for vhs mediated mRNA 
degradation. In experiments with the purified vhs protein, 
the same type of polysome salt washing procedures can be 
undertaken in an effort to determine what polysomal factors 
are required. 
In theory, then, a minimal in vitro degradation system 
could be established consisting of the purified vhs protein, 
polysome salt washes (if required), and messenger ribonucleo-
proteins. This minimal system would further simplify the 
identification of ancillary factors in the degradation of 
mRNA, and may lead to a better understanding of the pathway 
of that degradation. Most importantly, this system will 
allow an unambiguous determination of the way in which 
targeted mRNA is degraded. 
This issue points to the central unanswered question 
concerning the vhs function, which is whether the vhs protein 
is itself a ribonuclease or activates a cellular nuclease, 
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perhaps one involved in the normal turnover of mRNAs in unin-
fected cells. Attempts to demonstrate a ribonuclease acti-
vity in preparations of disrupted wild type virions were 
unsuccessful (Figure 19). The reason for this may simply be 
that methods of virion disruption that preserve the ribo-
nuclease activity have yet to be found. Alternatively, one 
or more cellular macromolecules may be required for vhs 
activity. The similarity of the biochemical characteristics 
of the vhs induced activity to those of in vitro degradation 
systems from uninfected cells (175) is consistent with this 
second possibility. Fractionation of the vhs mediated degra-
dation system as described above may resolve this issue. 
These proposed experiments will hopefully begin to 
answer some of the central questions about the vhs function. 
The vhs function is one of the few trans-acting factor that 
affects the stability of messenger RNA identified to date. 
As such, it provides a very useful tool in the examination of 
the role that mRNA stability plays in both cells and viruses. 
Whether it functions directly or indirectly, the vhs function 
is the first major avenue available for the fine dissection 
of this important issue. 
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